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ABSTRACT 
This project attempts to distinguish between two pulmonary disorders, asthma and pneumonia, 
using automated analysis of lung sounds. Such an approach minimizes the subjectivity of 
diagnosis inherent to current practices by physicians. Breath sounds are recorded by a 
physiological microphone and hardware acquisition system, and then analyzed in software using 
a two stage algorithm. The first stage detects abnormal lung sounds and second stage makes a 
diagnosis. A clinical trial was conducted at a pediatric clinic to validate the system.  
 6
TABLE OF FIGURES 
 
Figure 1 – Respiratory system ...................................................................................................... 12 
Figure 2 – Traditional Stethoscope ............................................................................................... 17 
Figure 3 – Nonlinear frequency response of a Littmann Classic II Stethoscope.......................... 19 
Figure 4 – Patent diagram............................................................................................................. 21 
Figure 5 – Objectives Tree............................................................................................................ 31 
Figure 6 – Weighted Objectives Tree ........................................................................................... 33 
Figure 7 – Sub-objectives of Objective A..................................................................................... 34 
Figure 8 – Sub-objectives for Objective B ................................................................................... 36 
Figure 9 – Sub-objectives for Objective C ................................................................................... 37 
Figure 10 – Sub-objectives for Objective D ................................................................................. 40 
Figure 11 – Microphone Design Alternative ................................................................................ 41 
Figure 12 – Vibration Sensor Design Alternative......................................................................... 42 
Figure 13 – Cough Detection Design Alternative......................................................................... 43 
Figure 14 – Cough Detection Design Alternative with Air Blocking Barrier .............................. 44 
Figure 15 – Air Flow Detection Design Alternative..................................................................... 45 
Figure 16 – A Second Air Flow Detection Design Alternative .................................................... 46 
Figure 17 – Combination Design Alternative............................................................................... 47 
Figure 18 – Drug-Induced Response Design Alternative ............................................................. 48 
Figure 19 – Imaging design alternative, showing x-ray imaging as an example.......................... 49 
Figure 20 – Block diagram of Microphone System Design ......................................................... 62 
Figure 21 – Early hardware circuit design.................................................................................... 63 
Figure 22 – Whistling sound and breath sound recordings made through stethoscope................ 64 
Figure 23 – Foam padding shell.................................................................................................... 65 
Figure 24 – Rubber cylinder handle on microphone .................................................................... 66 
Figure 25 – Final hardware design in clinical setting ................................................................... 66 
Figure 26 – Spectrogram of a generally healthy lung sound ........................................................ 67 
Figure 27 – Spectrogram exhibiting lung sound crackles............................................................. 68 
Figure 28 – Flowchart of Crackle Detection Algorithm............................................................... 69 
Figure 29 – Spectrogram exhibiting lung sound wheezes ............................................................ 70 
Figure 30 – Flowchart of Wheeze Detection Algorithm .............................................................. 71 
Figure 31 – Six locations of recorded lung sounds....................................................................... 72 
Figure 32 – Clinical trial setup...................................................................................................... 76 
Figure 33 – Results from subject 31 (diagnosed with pneumonia) .............................................. 78 
Figure 34 – Results from subject 8 (diagnosed with asthma)....................................................... 79 
Figure 35 – Results from subject 34 (no clinical diagnosis - healthy).......................................... 80 
Figure 36 – Diagnostic scores....................................................................................................... 81 
 
 7
LIST OF TABLES 
 
Table 1 – Stethoscope-related Patents .......................................................................................... 20 
Table 2 – Main Objectives: Pair-wise Comparison Chart ............................................................ 31 
Table 3 – Correct Diagnosis Objectives: Pair-wise Comparison Chart........................................ 31 
Table 4 – User Friendly Objectives: Pair-wise Comparison Chart............................................... 32 
Table 5 – Patient Friendly Objectives: Pair-wise Comparison Chart ........................................... 32 
Table 6 – Inexpensive/simple Objectives: Pair-wise Comparison Chart...................................... 32 
Table 7 – Using Weighted Objectives to Select Design from Alternatives.................................. 50 
 
 8
PART I – PROPOSAL 
CHAPTER 1 – INTRODUCTION 
Lung-sound based respiratory diagnosis is an age-old science. For hundreds of years, doctors 
have been listening to the noises produced by the lungs and attempting to draw conclusions 
about the inner workings of the body. Laënnec’s invention of the stethoscope in 1816 was a 
major advancement in the science of auscultation, as it was the first tool – besides the naked ear 
of a doctor – to aid in the process of listening and diagnosing of disease or physiological 
malfunction. 
Since then, pulmonary sounds have become very important to the field of medicine. Their 
widespread diagnostic utilization by physicians demonstrates a clear need for a high level of 
reliability. However, since the invention of the stethoscope, very few instruments have been 
developed to improve lung auscultation. The most popular device remains the stethoscope, which 
still requires the skill of a doctor – a human interpreting the sounds of the lung, based partially 
on his or her own experience, and partially on arbitration, a situation that induces a substantial 
risk for human error during auscultation analysis and ultimately disease diagnosis (Mahnke 1). 
Hardly any control or benchmark exists to verify the personal observations of a physician or 
quantify and systematically analyze the problem on a more sophisticated level. Doctors 
themselves admit that the process is highly speculative (Eder, Thomas. Personal Interview. 22 
Sept. 2004). Such ambiguity in the analysis sometimes leads to erroneous diagnosis and 
treatment. For example, pneumonia and asthma produce very similar sounds and are extremely 
difficult to differentiate. Further tests, such as lung x-rays, are often prescribed to further analyze 
a patient’s condition, but such tests are time consuming and costly. Several studies have provided 
evidence of such approach being a widespread difficulty (Hay 1).  
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In contrast to the stethoscope, the field of electronics has advanced rapidly over the past century, 
and there has been enormous growth in many related industries (Gavriely “Foreword”) that has 
encouraged the development of medical technologies. There has been steady progress in digital 
audio processing, as well as an increased understanding of the physiology of the respiratory 
system and how it produces sounds. 
This project proposes to automate the process of diagnosis, to place it in the more objective care 
of programmed electronic circuitry. Specifically, the project would: 
(1) begin to define a standard automated method by which respiratory ailments, 
particularly asthma and pneumonia, are determined from lung sounds, 
(2) build a prototype device that would be tested and optimized (through a study that 
would have normal and diseased subjects), and ultimately 
(3) allow the doctors to focus their skills on the holistic diagnosis in which humans 
excel, rather than the rote data processing required by lung sound analysis, an area 
in which the computer is superior.  
The possibility of performing more sophisticated pulmonary sound analysis and perhaps 
diagnosis with an automated device is very favorable. Such a device could serve as a substitute 
for a traditional stethoscope, while affording a reduction in human error from the pulmonary 
diagnosis. 
The ultimate goal is to create a cost effective device to decrease the cost of diagnostic healthcare. 
With the proposed simple structure of the device, low cost is a realistically attainable goal. A 
challenge for any new technology to enter the doctor’s office is enormous. Current attempts to 
improve the traditional acoustic stethoscope have not been widely accepted by physicians. 
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However, a simple to use device with established diagnostic validity may have a good chance to 
become popular among the healthcare professionals. 
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CHAPTER 2 – LITERATURE REVIEW 
To become familiarized with the problem at hand and to gain a deeper understanding of the 
current state of the pulmonology industry, the authors examined current literature, manufacturer 
specifications, and historical documents for information regarding stethoscopes, general 
pulmonology, and digital sound analysis. The three sections of this chapter will summarize the 
findings about the physiology and diagnostic importance of pulmonary sounds, past and present 
methods of pulmonary auscultation, and trends in digital sound analysis techniques. This 
background information is intended for an individual with no specialized knowledge base in the 
field of pulmonology or signal processing. It is organized into sections that follow a probable 
chronological path for the respiratory signal to pass through the system. 
Respiratory Sounds 
During pulmonary auscultation, there are two general classes of sounds that can be heard: normal 
and adventitious. Normal breath sounds, originating in the trachea and bronchia, or in the lung 
vesicles, are generated by the unaltered ventilatory cycle. Adventitious sounds are abnormalities 
in the normal sound, and are usually indicative of specific abnormalities in the normal breath 
cycle. 
Normal tracheal breath sounds 
These sounds, generally recorded over the trachea, are generated by the turbulent air flow 
through the upper airway. Harsh in nature, their amplitude is directly related to the amount of air 
flowing through (and resultant turbulence in) the passages of the upper airway: the trachea, the 
epiglottic region, and the pharynx. Tracheal sounds cover a frequency range from approximately 
100 Hz to 1.5 kHz, with the greater part of the signal below 800 Hz (Pasterkamp 979). The peaks 
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and troughs in a frequency spectrum of a tracheal sound have a correlation to the airway 
dimensions, the gas mixture, and the body height of the subject (Dalmay 1765). 
Because of the numerous factors that influence tracheal breath sounds, they can be used 
diagnostically in a number of different ways. For example, sleep apnea can be detected by using 
the sounds to determine air flow. Disorders in which inspiratory flow is obstructed can also be 
monitored, as this obstruction affects the tracheal sound (Pasterkamp 979). 
 
Figure 1 – Respiratory system 
[Leslie Laurien, MSMI, American Medical Association] 
Normal vesicular breath sounds 
There are also normal breath sounds that occur throughout the lungs. These can be heard close to 
the chest wall. Their amplitudes vary greatly over the chest and back; but they are strongest 
where air flow is the highest. The exact cause of these sounds during the inspiratory stage of the 
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breath cycle, though not certain, has been explained by numerous theories (R.A.L.E. “Normal 
Sounds”). It is possible that they are produced by the redistribution of gas, or by the stretching of 
lung tissue during inspiration (Dalmay 1767). During expiration, the audible sounds are 
generated by the passage of air through central airways. An air-filled lung behaves as a low-pass 
filter, so vesicular breath sounds are only substantial at frequencies from zero to approximately 
400 Hz (R.A.L.E. “Normal Sounds”). 
Due somewhat to the relationship between air flow and vesicular lung sound amplitude, it is 
possible to detect obstructive pulmonary disease from a definitively reduced amplitude 
(Pasterkamp 978). Also, a difference is propagation delays of the lung sounds traveling the same 
distance in different directions through the lung may suggest inhomogeneity in ventilation 
between parts of the lung, an indication of small airways disease (Pasterkamp 979). 
Adventitious sounds 
Besides inconsistencies in the propagation of the normal lung sounds, there are also several types 
of specific irregularities that can be heard in respiratory sounds. They are classified into two 
broad categories: wheezes, which are continuous and “musical”, and crackles, which are 
discontinuous. 
Wheezes 
Wheezes are continuous, as their durations are longer than 80 milliseconds, and often musical, as 
the length allows intrinsic tones to be heard as pitches, or sinusoidal signals with frequencies 
generally between 100 Hz and 1 kHz. Because of this, it is fairly easy to identify a wheeze with 
the ear, as there are sharp peaks in the power spectrum, the intensity of which can be related to 
the intensity of the normal lung sound (Pasterkamp 980). Wheezes with a very low pitch are 
referred to as rhonchi (R.A.L.E. “Adventitious Sounds”). 
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Wheezes are thought to be produced by the fluttering of airway walls that occurs when the air 
flow exceeds a certain velocity at a given passageway diameter (Pasterkamp 980). Thus, this 
type of sound will only occur when the air has sufficient force, and the path of the air flow has 
been limited in some way. It is possible to induce a forced expiratory wheeze by increasing the 
air flow in a healthy subject; however, the source of this type of wheeze may vary slightly from 
that of a wheeze triggered by a disease-related limitation of the normal flow. Asthmatic subjects, 
for example, often exhibit spontaneous wheezing during not only expiration, but also inspiration, 
a condition not reproducible in healthy subjects (Pasterkamp 980). 
Wheezes can be used clinically to quantify airway flow obstruction, by determining the fraction 
of breathing accompanied by wheezing to normal breathing. Wheezing can also predict the 
existence of large airway secretions. However, caution should be used while diagnosing, as it is 
possible for spontaneous wheezes to be generated without any flow limitation whatsoever, and 
for the vibrations to be induced during tidal breathing. Also, wheezing may be absent in cases 
where there is obstruction of flow (Pasterkamp 980). 
Crackles 
Crackles, with a length of between 10 and 20 milliseconds, are thought to be produced by the 
sudden opening or deformation of airways. Bubble movement through fluid or secretions can 
also cause them (R.A.L.E. “Crackles”). Crackles are generally heard only during inspiration, and 
their occurrence (unlike that of wheezing) cannot be reduced by coughing (Pasterkamp 982). 
The category of crackles is further divided into two types: fine and course. Fine crackles are 
higher pitched, and sound drier than their course counterparts. Each type of crackle is generally 
indicative of a particular respiratory disease (Piirilä 2140). Ultimately, crackles are perhaps the 
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best of the lung sounds for diagnosis: a diagnosis could depend on the timing of the crackles in 
the breathing cycle, their intensity, prevalence, and spatial location within the lung (Pasterkamp 
982). 
Coughs 
A respiratory sound common to almost all respiratory diseases is coughing. Coughing is not only 
characteristic of being ill. It is an essential mechanism for lung defense and protection of the 
airway. So whether a person has a pathological respiratory condition or has healthy lungs, any 
danger posed on the lungs and airway may induce coughing. An effective cough starts with a 
large inspiratory effort, closure of the glottis, and finishes with a rapid contraction of the 
abdominal and chest wall muscles, coordinated with the re-opening of the glottis. This sequence 
creates an explosive egress of compressed air, with air speeds reaching approximately one third 
the speed of sound along the walls of the narrowed larger airways. The resulting “scrubbing 
action” along the airway walls is effective in keeping foreign bodies out and expelling anything 
that may be obstructive or toxic to the lungs (Gavriely, Cugell).  
Although it can just be a sign of irritation, coughing is often a sign of disease in the respiratory 
system, and is usually more frequent and more severe when a result of disease. Disease in the 
lungs can cause an accumulation of mucus or an inflammation of the airways. Past studies of 
cough patterns in patients with lung disease have been limited to determining the number of 
cough episodes or paroxysms and the number of coughs per episode. Cough counts are useful, 
and this measurement can now be automated for determination of effect of antitussive (cough 
suppressive) medication and for monitoring nocturnal cough episodes in asthmatic patients 
(Gavriely, Cugell). 
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Coughs that are as a result of different ailments may have different audible acoustic 
characteristics (e.g. dry, productive, croup). However, these characteristics are very difficult to 
detect and analyze otherwise (e.g. in a digital representation). In the time domain, these sounds 
are a series of explosive noises. Measurements of the acoustic features of voluntary cough 
sounds in healthy subjects have been reported by several groups (Gavriely, Cugell). 
Measurements of acoustic properties of cough, duration of the cough sound, and the relationship 
of the sound to the time of glottic closure are some differences that may differentiate between 
lung diseases. For example, in a study by Piirila (46), the highest frequency components of 
cough sound were found to have lower amplitudes in asthmatic subjects than in chronic 
bronchitis subjects. 
Cough sounds are easily acquired using free field microphones and can be analyzed digitally. 
Modified voice recognition systems have been used for this purpose in several studies and have 
been found to be fairly accurate (Gavriely). 
Respiratory Diseases – Asthma and Pneumonia 
Asthma is defined as a disease process that causes bronchoconstriction, and thus makes breathing 
more difficult. This condition is exasperated by allergic reactions, changes in temperature or 
humidity, infections of the upper respiratory system, exercise, stress, or cigarette smoke. The 
constriction of the respiratory paths can cause wheezing, especially when the condition is 
provoked by the irritants mentioned above. 
Pneumonia, another respiratory disease, is caused by an infection in one or both lungs. It is often 
caused by bacteria or virus, or sometimes by a fungus or other organism. Certain populations 
(especially the very young and elderly) are prone to pneumonia infections. The symptoms are the 
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same as of any other respiratory infection (fever, coughing, chest pains), but generally with 
pneumonia, there is also discolored fluids and sputum in the respiratory tract. Bubbles can form 
in the fluid, causing crackles and other sudden lung sounds. Because of the impedance of the 
disease on the flow of air, some wheezing may also be evident. 
Evolution of the Stethoscope 
The traditional acoustic stethoscope is a three-part device; it consists of a chest piece to pick up 
the sounds, earpieces for the user, and rubber tubing connecting the two ends. This configuration 
was developed in the mid-1940 and has been effectively unchanged to today. The stethoscope 
serves a fairly simple task – to transfer the pulmonary sounds from patient to physician – and 
modern technology has done little to change the acoustic properties of the device. 
 
Figure 2 – Traditional Stethoscope 
[Belgian Center for Evidence Based Medicine] 
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The rubber tubing of the stethoscope has a unique transfer function which predictably distorts the 
acoustic signal as it passes through (Figure 3). Physicians are taught to analyze the distorted 
sounds in daily practice. Modern advances in electronics allow for a more sophisticated approach 
and a cleaner signal reproduction. Thus, an electronic version of a stethoscope, implementing 
even a simple microphone-amplifier-speaker circuit, would be able to offer more functionality 
than their acoustic counterparts. There are several electronic stethoscope devices on the medical 
device market today, but they are not widely accepted by the practicing physicians. This 
unpopularity could be due to high costs, the unfamiliarity of doctors with the use of modern 
technology, and the modified acoustic properties of the sounds they reproduce. 
Some of the products available are manufactured by brands such as Androscope, 3M Littmann, 
Meditron, and Cardionics (Some devices are described in Appendix B). These stethoscopes, 
offered at prices competitive with the traditional acoustic stethoscope, generally function as bug-
for-bug compatible replacements for them, reproducing their notoriously nonlinear frequency 
responses. The majority of electronic stethoscopes offer at least two operating modes, akin to the 
tunable diaphragm on an acoustic stethoscope: the “bell” mode accentuates the lower frequencies 
of heart sounds, and the “diaphragm” mode accentuates the higher frequencies of lung sounds. 
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Figure 3 – Nonlinear frequency response of a Littmann Classic II Stethoscope 
[3M Littmann] 
Oftentimes, electronic stethoscopes offer control over the degree of amplification performed by 
the instrument by simply adding a volume control. Several products, such as those made by 
Andromed, offer additional functionality. Instead of merely duplicating the collected sound 
signal in the stethoscope’s earpieces, they include provisions to digitally record the sound, and 
perhaps transfer the digitized signal to a computer or a PDA (Personal Digital Assistant). This 
option allows lung sounds to be displayed and even analyzed digitally. A few products do offer 
digital analytical functions, however none have actually realized more than a counter for the 
number of adventitious sounds. Even with the most advanced commercially available product, 
the task of diagnosis still relies completely on the human.  
In addition to a number of manufacturers with advanced electronic stethoscope designs, the field 
is rich with patents yet to become reality. Electronic stethoscope patents range vastly in the 
degree of difference from the traditional stethoscope. Some offer a mere amplification of lung 
sounds, others allow the sounds to be digitally recorded, compared to previous records, and even 
visually analyzed. A number of patents draw on the device’s ability to connect to a personal 
computer, but there are some that are meant to function as a stand-alone unit. Other domains of 
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patents encompass modifications to very specific parts of the stethoscope, such as the sound 
pick-up head. (Table 1 details several patents related to the stethoscope.) 
Table 1 – Stethoscope-related Patents 
Patent # Year Title Key Advances 
US8591 1861 Stethoscope and Ear Trumpet 
First binaural stethoscope 
US693487 1902 Stethoscope 
Flexible ear pieces 
US3108652 1963 Stethoscope 
Modern Littman design 
EP0295318 1988 Electronic Stethoscopic Apparatus 
Multiple auscultation recording 
RU2130755 1999 Sensor of an Electronic Stethoscope 
Decreased artifact noise 
WO 00/2486 2000 Analytic Stethoscope 
Handheld electronic device with 
graphical display 
US6083156 2000 Portable Integrated Physiological Monitoring System 
Multiple variables recorded; 
interfaces wit ha PC 
US6324289 2001 Pick-up Head for an Electronic Stethoscope 
Bell is acoustically decoupled 
from the pick up element 
US6396931 2002 Electronic Stethoscope with Diagnostic Capability 
Self contained, handheld unit 
with diagnostic capability 
US2003002685 2003 Electronic Stethoscope 
Emphasize sounds based on 
pathological conditions 
US2003/0072457 2003 Electronic Stethoscope 
Several operation modes 
traditional spectral properties 
US2004/0096069 2004 Electronic Stethoscope 
Filters audio signals; selects 
between band-passed inputs 
 
Ideas can also be patented; one example is a patent filed in 2002 by Cybercare Technologies of 
Boynton Beach, Florida. The document describes a generic system and method of developing a 
packet based electronic stethoscope. Figure 4 demonstrates that, more than anything, the patent 
resembles a flow chart of connected “black boxes”. 
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Figure 4 – Patent diagram 
[US Patent and Trademark Office] 
Recent research by Murphy et al has attempted to implement an automated diagnosis of 
pneumonia. The study is based on the premise that it is possible to make a diagnosis based on the 
presence of crackles in the lung sound. It used an array of microphones placed on the back to 
record and integrate simultaneously acquired spatial data. The conclusions indicated that 
auscultatory diagnosis in patients with pneumonia can be conducted by a computerized technique 
(Murphy 1496). Our project is similar to but also extends the work of Murphy in that we are 
focusing on distinguishing between asthma and pneumonia, and not just diagnosing pneumonia. 
Frequency Content of Lung Sounds 
Hardware filtering and frequency domain analysis are useful functions that can be implemented 
using electronic components. Pulmonary sounds can be filtered based on the frequency content. 
The main energy of lung sounds is carried within frequencies below 100 Hz (Welsby 695). Many 
abnormalities typical for specific lung diseases have their own specific frequency bands. For 
instance, wheezes usually occur at frequencies above 400 Hz and crackles occupy the bandwidth 
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between 750 and 1200 Hz. Based on these frequency distinctions, along with other more specific 
criteria, it appears possible to filter, selectively amplify, and ultimately identify specific sound 
patterns using automated equipment. Quantifying the process removes human error from the 
equation and replaces it with precise mathematical calculations. Doctors have always held a 
crucial part in medical diagnosis; allowing a computer to take over even a small part of 
pulmonary disease identification is no small or easy step for the healthcare industry. 
Digital Software Applications 
After the hardware acquisition and hardware-based signal processing, the lung sound signal is 
converted into a digital format, and acquired by computer software. The pulmonary signal is then 
further filtered and analyzed digitally. The signal can also be represented in various formats, 
including frequency and time domain representation. Fast Fourier Transforms (FFTs) (Gavriely) 
and Wavelet Transforms (Kandaswamy 523) have been used to represent signals in terms of their 
frequencies, which can then be used to classify the sound signals into particular categories, based 
on the type of lung sound that they represent. Since certain categories of abnormalities are 
characterized by specific frequency content, successful identification is possible, but since 
overlap of ranges may also cause uncertainties in this process, it is prudent to recruit more 
decisive characteristics for classification. Computer software such as LabVIEW® and 
MATLAB® can be used to do such analyses. 
Alternatively, several existing product packages can aid in the identification of individual 
adventitious sounds in a lung sound recording, instead of designing LabVIEW® or MATLAB® 
software from scratch to examine recordings. 
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• The DSP Sona-Graph is a dedicated (i.e., not computer-based), real-time, audio spectrum 
analysis instrument designed for high speed signal analysis and display.  
• Another product, the Sonogram, is from the German Research Center for Artificial 
Intelligence (Deutsches Forschungszentrum für Künstliche Intelligenz, DFKI).  
o It is a tool to analyze speech and sound signals using FFTs, cepstral analysis, 
autocorrelation, wavelet-transformation, and a linear-predictive-coding method 
mostly used for speech recognition.  
o The ultimate goal of the Sonogram project is to develop a speech recognizer that 
works internally with Hidden Markov Models. At this time, however, only the 
signal analysis functionality has been implemented; it is missing many speech 
recognition tools (Gavriely). 
Another option for adventitious sound classification is the use of Artificial Neural Networks 
(ANNs), which do have a precedent for use in diagnosis. ANNs are information-processing 
paradigms inspired by the way biological nervous systems, such as the brain, process 
information. They are composed of a large number of highly interconnected processing elements 
(suggestive of neurons) working collaboratively to solve specific problems. ANNs, like people, 
learn by example; one must undertake a learning process for a specific task, such as pattern 
recognition or data classification, before it is able to function. Artificial neural networks have a 
remarkable ability to derive meaning from complicated or imprecise data, and can extract 
patterns and detect trends that are too complex to be noticed by either humans or more 
conventional algorithmic computer techniques. However, because the network finds out how to 
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solve the problem by itself, its operation can be somewhat unpredictable, a quality not desirable 
for a medical standard (Stergiou 1.4). 
The final function of the system may also be implemented in software. After identifying specific 
abnormalities in the lung sound recording, the system must determine if the annotated recording 
satisfactorily matches that of a known disorder, and suggest a suitable diagnosis. 
The importance of pulmonary diagnostics in healthcare 
The prevalent use of lung sounds in health diagnosis is clearly exemplified by the one tool 
doctors wears around their neck – a traditional stethoscope. Lung sounds are one of the important 
physiologic signals that can be examined non-invasively by doctors: the amount of clinical 
information that can be collected through auscultation is colossal.  
According to the chairman of the Federation Internationale Pharmaceutique (Tromp), fifty 
percent of medications prescribed around the world are not used properly. This number is largely 
due to over-prescription practices common to many physicians. Professionals admit to this trend 
caused by a simple philosophy – it is better to be safe than sorry. For instance, antibiotics are 
often prescribed with the slightest chance of pneumonia. Such a simplified solution has many 
drawbacks – the cost of unnecessary medication and the possible futility or side-effects of 
needless drugs are just a few. With more sophisticated diagnosis procedures, misuse of drugs can 
be largely decreased: the more specific the diagnosis, the more appropriate the prescription. 
Current methods of pulmonary disease diagnosis rely heavily on the interpretation of doctors. 
Unfortunately, subtle differences between asthma and pneumonia are not easily distinguishable 
by the human ear. Long experience in the medical practice will certainly eliminate much of the 
guesswork, but the ability to diagnose may be compromised by the deteriorating hearing of older 
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doctors. Aiding professionals with automated diagnostic equipment seems a good solution for 
the healthcare community. An automated diagnosis also allows the doctor to direct his or her 
attention to other aspects of patient examination. Ultimately, a nurse or a technician could use 
the device to take the readings and present the doctor with a completed analysis. This decreased 
examination time would allow the physician to serve more patients. 
 26
CHAPTER 3 – PROJECT APPROACH 
This project was originally conceived by Dr. Thomas Eder, a practicing pediatrician in 
Worcester, Massachusetts. He envisioned technology filling a much larger role in respiratory 
diagnosis, a large change from the status quo use of the acoustic stethoscope, which had 
remained largely unchanged for decades. 
After the first meeting with Dr. Eder and conducting some initial research, the original problem 
statement was established: 
This project will attempt to optimize the design and manufacturability of an 
electronic stethoscope, as well as to increase the respiratory diagnostic 
functionality of the product. 
This focus was mainly brought about by an interest in determining the reason for the large 
discrepancy between the advancement of electronics and the actual use of new technology in 
pulmonary analysis and diagnosis. The initial speculation, that electronic stethoscopes may be 
too expensive to be widely used, brought about the formulation of the original problem 
statement.  
Further research and a realization that the problem statement could limit the design process to a 
particular solution (just a modified use of the stethoscope for pulmonary diagnosis) prompted us 
to broaden our problem statement to encompass more generic respiratory signal analysis, and 
refocus on a specific problem, instead of a specific solution. The revised problem statement is as 
follows:  
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Design a low-cost respiratory signal classification system that will diagnose 
respiratory abnormalities, and, in particular, distinguish between pneumonia and 
asthma, two disorders that are commonly misdiagnosed. 
Part of the project definition came from realizing the project’s budget constraints. Another 
important modification to the definition is the emphasis on the development of a system – and 
not just an instrument or device. With the given objectives, it seemed best to approach the 
problem from a multifaceted perspective. 
An additional motivation came through findings from our research that some current work had a 
related focus; Murphy et al are working on automated pneumonia diagnosis system (Murphy).  
The first stage of the system will be dedicated to detecting and acquiring respiratory sounds. 
Some objectives of this sub-system are amplifying the biological signal, filtering the sounds, and 
converting them to digital signals. Preliminary signal processing will most likely take place in a 
dedicated circuit. The second stage of the system will digitally analyze the signals. This would 
result in classification of the signals into categories of particular abnormalities, including 
wheezes and crackles (sounds characteristic to various pulmonary disorders, as discussed in 
Chapter 2). Theoretically, by detecting the presence of such abnormalities and comparing their 
prevalence in lung sounds of various patients, it will be possible to make a valid diagnosis. 
The idea of such a system stems from contemporary research concerning respiratory sounds. The 
frequency content of lung sound abnormalities has been found to vary from that of normal lung 
sounds. Thus, analysis of lung sounds in the frequency domain can subsequently lead to 
automated diagnosis. Instruments used for pulmonary sound detection and digitization are 
already on the market, while others are in development and research stages. Due to the apparent 
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prevalence of computer software performing similar applications, it was suspected that it would 
also prove to be the best technique to analyze signals from the lung. However, other methods 
were considered in the design process. 
The summary above focuses on the engineering aspect of the project, based on the assumption 
that an automated algorithm could be used to diagnose pulmonary disorders. We assume that 
there exists a one-to-one correlation between combinations of abnormal lung sounds and specific 
disorders, for the purposes of diagnosis. Following the completion of the engineering phase, we 
will conduct a scientific study in a clinical setting, in which we will test the hypothesis that our 
system is able to diagnose pulmonary disorders accurately. 
By clearly defining a method of identifying physiological disorders, we hope to substantially 
reduce human errors common in diagnosis using traditional instrumentation. 
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CHAPTER 4 – DESIGN 
The process of designing the system to distinguish between asthma and pneumonia was well 
defined and organized, consistent with the method set forth by Dym and Little (2003). The five 
step process was followed as closely as possible, in order to generate the best possible system to 
meet the project objectives. 
The first principal action in the design process was to define the problem the project was 
intended to solve. Several interviews and much background research helped to establish this 
goal, as presented in Chapter 3. The design team also visited a pediatric clinic in order to 
experience and evaluate the current process of auscultation. The final part of the problem 
definition was designation of the functions of the desired system, the constraints involved in the 
project, and the requirements imposed by the users. 
The primary function of the system, of course, was to distinguish between the lung sound 
symptoms indicative of asthma and those specific to pneumonia. A number of secondary 
functions were accomplished to fulfill this diagnosis function, including acquiring respiratory 
sounds, amplifying them, and passing the sounds to the client while digitizing them. The system 
also had to be designed to interface with a personal computer or personal digital assistant device 
in order to complete some of the main functions, and for the purposes of displaying and 
recording the captured sounds. 
Several constraints affected the design. Because of the medical use of the system, it had to meet 
federal medical device health and safety requirements. Due to the academic nature of this 
project, the system was developed and tested for less than $450 over a period of approximately 9 
months. 
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The client and users of this system have set minimal requirements, which the final design must 
meet in order for it to be considered a success:  
• It should acquire the audio respiratory signal with high fidelity and minimum noise.  
• Any handheld elements should be lightweight.  
• Any device, along with all connected accessories, should be easy for the users to 
transport from room to room.  
• It should be of the correct proportions to be used comfortably by the users, and should 
not require an unreasonable amount of power so as to be unsafe for the users.  
• Finally, the system should diagnose with an accuracy that exceeds current methods (i.e. a 
doctor’s intuitive diagnosis). 
The specifications presented above made up an elaborate scientific and engineering problem. 
Given the novelty of the project and the fact that a marketable solution for the problem had not 
yet been realized, prior to attempting the design, it was necessary for the team to develop a much 
deeper knowledge base than it currently possessed. This expertise comprised the fields of 
pulmonary diagnostics, audio acquisition, and digital sound processing. The findings are 
discussed in the Literature Review Chapter. 
Needs Analysis and Specifications 
Following our preliminary research and establishing of a problem statement, we began to further 
specify the requirements for our design. We created a nested objectives tree, as shown in Figure 
5. Each of the smaller boxes illustrates a sub-objective of the objective above it. 
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Figure 5 – Objectives Tree 
These objectives were assigned percentages, based on the results of a series of pair-wise 
comparison charts, shown below. For these tables, we compared each objective against each 
other objective, establishing rankings for use in weighting the objectives. 
Table 2 – Main Objectives: Pair-wise Comparison Chart 
Objectives Correct diagnosis 
User 
Friendly 
Patient 
Friendly Inexpensive Score 
Correct 
diagnosis ♦♦♦♦♦ 1 1 1 3 
User 
Friendly 0 ♦♦♦♦♦ 0 0 0 
Patient 
Friendly 0 1 ♦♦♦♦♦ 0 1 
Inexpensive 0 1 1 ♦♦♦♦♦ 2 
 
Table 3 – Correct Diagnosis Objectives: Pair-wise Comparison Chart 
Objectives Agrees w/ accepted Reproducible Reliable Score 
Agrees w/ 
accepted ♦♦♦♦♦ 1 1 2 
Reproducible 0 ♦♦♦♦♦ 0 0 
Reliable 0 1 ♦♦♦♦♦ 1 
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Table 4 – User Friendly Objectives: Pair-wise Comparison Chart 
Objectives Intuitive output Fast analysis Score 
Intuitive 
output ♦♦♦♦♦ 1 1 
Fast analysis 0 ♦♦♦♦♦ 0 
 
Table 5 – Patient Friendly Objectives: Pair-wise Comparison Chart 
Objectives Sanitized No Harm Non-frightening 
Small and 
Light Score 
Sanitized ♦♦♦♦♦ 0 1 1 2 
No Harm 1 ♦♦♦♦♦ 1 1 3 
Non-
frightening 0 0 ♦♦♦♦♦ 0 0 
Small and 
Light 0 0 1 ♦♦♦♦♦ 1 
 
Table 6 – Inexpensive/simple Objectives: Pair-wise Comparison Chart 
Objectives <$450 Completed in time Score 
<$450 ♦♦♦♦♦ 0 0 
Completed in 
time 1 ♦♦♦♦♦ 1 
 
The comparisons were used to generate specific weighting percentages for each objective and 
sub-objective, as shown in Figure 6. 
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Figure 6 – Weighted Objectives Tree 
To evaluate how well a design is meeting the objectives, they were clearly defined. Each 
objective is examined in detail below, giving an explanation for its importance and establishing a 
means of evaluating the designs. 
Gives correct diagnosis (Objective A, 35%) 
This objective means that the system is correct in reporting when a patient has asthma, is correct 
in reporting when a patient has pneumonia, and is correct when reporting that a patient does not 
have either disorder. For a medical system, giving the correct diagnosis is the primary objective. 
If it does not perform adequately, it does not matter how well any of the other objectives are met; 
the system is not acceptable. This objective is weighted at 35%, as it is more important than the 
lower two objectives. It is ranked equally, however, with the objective Inexpensive/Simple, as 
the academic nature of our project makes it just as important to be able to actually complete the 
design as to diagnose properly. 
This objective is further divided into three sub-objectives, each having to do with giving the 
correct diagnosis. 
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Figure 7 – Sub-objectives of Objective A 
Agrees with accepted values (Objective A1, 40%) 
This sub-objective is defined by the agreement of the system with an accepted diagnosis. This 
assumes that a definitive diagnosis can be obtained that is accepted by the medical community – 
this diagnosis can be through means not usually used in everyday diagnosis, or through a means 
that would preferably not be used (such as drug-induced response or some type of radiation 
imaging). This is the most important sub-objective, as it is the essence of being correct – the 
system must agree with what we feel is the most accurate answer we have. It is measured by 
comparing the system’s responses (or predicted responses) with the “real” (accepted) value. The 
more times there is agreement, the higher the score. 
Reproducible (Objective A2, 25%) 
This sub-objective signifies that the system must give consistent results. That is, given the same 
input (i.e. the same patient), the diagnosis must be the same. Even if the system is “correct” a 
certain percentage of the time (and thus received a high score for the previous sub-objective), it 
is important that the certain percentage of correctness is high. This is measured by using the 
system multiple times on one patient, and scoring the system based on the correlation between 
the multiple results. 
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Reliable (Objective A3, 35%) 
This sub-objective means that the system will not malfunction or wear out over time. For any 
medical instrument, it is important that wear-and-tear not be excessive. Lower scores were given 
for systems with complex mechanical moving parts or parts that would have strain put on them, 
as they are most prone to wear and breakage. Higher scores were given for systems without such 
components. 
User Friendly (Objective B, 10%) 
When an instrument is user-friendly, this generally means that those using the equipment work 
with it at the optimal ease of understanding and operation. They would have a user interface that 
helps them understand what the machine is doing, tells what they should do in order to have the 
desired output, provides a reasonable reflection of how long the machine’s operations take, and 
finally indicates when they should actively interact with and operate the equipment. This ensures 
efficiency in working with the equipment and reasonably quick detection of any malfunction and 
the correction thereof. Usually, more user-friendly equipment triggers less anxiety and 
frustration in its users. When a machine is not very user-friendly, it usually requires the users to 
spend more time actively operating it than is needed, and may advocate unreasonable mishaps. 
This leads to unnecessary anxiety, frustration, and wasting of time. With other objectives having 
been met well, user-friendliness is not too difficult to achieve. With the use of computers, it can 
become very simple. 
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Figure 8 – Sub-objectives for Objective B 
Intuitive output of data (Objective B1, 60%) 
This means that when the results are being observed at the system’s display, the values, changes, 
and trends are easily interpreted and are representative of what is actually happening. This makes 
it easier to understand and the results are more quickly interpreted and utilized in any subsequent 
analysis (e.g. diagnosis). In the case of this project, the easier it is for users to correlate displayed 
results and the actual condition, the greater the weight assigned to that system. 
Fast analysis (Objective B2, 40%) 
Any analysis that should be done (taking the current measurement, comparing it to a standard 
value, and understanding the implication) would be done in as little time as possible. This 
enables users to obtain a diagnosis quickly and to prescribe a corrective measure in a timely 
fashion. The less time it takes to do the necessary analyses using a particular system, the greater 
the weight assigned to that system. 
Patient Friendly and Safe (Objective C, 20%) 
The device must be patient friendly and safe for the subjects. This objective is applicable for any 
technology implemented in the healthcare field. The device designed to, in one way or another, 
improve the patient’s well-being can not produce a harmful effect. The definition of harmful can 
be quite broad; it may include mild or severe physical damage to the patient or even just a sense 
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of discomfort – physical or mental. Effects on the patient can be immediate or delayed. The goal 
of the design artifact should be to minimize any such unwanted effects. In this case, a device that 
causes severe damage to the patient is unacceptable as a diagnostic tool – any potential benefits 
of using the device are negated by its harm to the patient. 
The essential objective is that the overall health status of the patient does not deteriorate after the 
device is used. This broad definition covers any possible effects of the device. Finally, the 
average patient should not express emotional discomfort when the device is used. (An “average 
patient” is not one who will be inherently nervous by his mere presence in the doctor’s office.) 
 
Figure 9 – Sub-objectives for Objective C 
Able to be sanitized/disposable (Objective C1, 30%) 
The importance of maintaining the cleanliness of patient-contacting parts of the device comes 
from concerns of cross-patient contamination. When multiple patients come into contact with the 
same device, there is the possibility of carrying bacteria or other unwanted pathogens from one 
patient to another. Spread of disease is certainly unwanted in a healthcare facility. 
Avoiding this issue can be achieved by sanitizing the appropriate parts or replacing them with 
disposable components. Sanitizing can be achieved by wiping the part with an alcohol solution. 
As the design will be coming in contact only with the patient’s skin, sanitizing with alcohol is 
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sufficient. The material used will dictate the ability of the device part to be sanitized. For 
example, plastic or metal parts can be easily sanitized with alcohol swabs. If a part is made of 
cloth or rubber, or is excessively large, sanitizing might be challenging. 
Disposable parts ensure that each patient comes in contact with a new and clean part, thereby 
eliminating the need for cleaning. Almost any parts of equipment can be made disposable and 
replaceable. One of the few issues disposable parts introduce is additional cost. Depending on the 
size, shape, and material of the replaceable piece, it may be feasible to make it disposable. 
Conforms to regulations; no harm to user (Objective C2, 35%) 
Healthcare devices are very tightly regulated by various organizations and sets of rules. Federal 
Drug Administration is only one example of such control; other may include hospital specific 
regulations and rules set forth by local or national officials. 
Conformation to all applicable standards and regulations is important for any new design. If the 
device fails to meet any of the rules listed above, its use is unacceptable in the healthcare setting. 
Designers must be sure to meet or exceed any expectations for the device. 
Ensuring conformation to the rules is simply a check-list process. Once all applicable regulations 
are identified, the designer must simply go through the list of regulations and compare them to 
the device’s performance. In the case of multiple regulation sources, many points of testing will 
likely be redundant. 
Non-frightening (Objective C3, 15%) 
The device must not scare the patients. This property is applicable to both adults and children. In 
case of pediatric applications, it likely will have to meet stricter guidelines, for children are more 
apt to be uncomfortable or scared by an unfamiliar device in the doctor’s office. The goal of 
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being non-frightening is rather subjective – different people will certainly have a different 
reaction to the same device. As a general rule, the device should not appear overwhelming and 
unnecessarily large, should not produce unexpected visual stimuli, vibrations, or loud noises. A 
dental chair with a drill is an example of a frightening device; pulmonary diagnostics device 
should be much less discomforting. 
The patient response to the device can be identified by simple observation. If the patient looks 
uneasy, frightened, or even begins to cry – perhaps the device is not entirely non-frightening.  
Small and light (Objective C4, 20%) 
The device must be small and light to promote ease of use by the doctor. Bulky, heavy devices 
may cause physical and emotional patient discomfort, neither of which is desirable. This 
objective describes the overall device, as well as the parts that come in direct contact with the 
patient and require manipulation by the user. 
Size and weight considerations are relative among the design alternatives and are meant to 
emphasize the superiority of one above the others. Since this is a fairly uncharted research field, 
no golden standard of size and weight exists – except perhaps the traditional stethoscope. The 
mobile parts of the device can be compared to the stethoscope. Overall, device mobility is 
important. If the device can be moved from room to room, the diagnosis is simpler – the device 
can be brought to the patient, instead of the patient going to the device. 
Inexpensive/Simple (Objective D, 35%) 
Usually, the simpler equipment is, the more inexpensive it is. This is mainly due to the fact that it 
is easier to manufacture or fabricate. Any work on production of the equipment will also done in 
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a shorter amount of time. The equipment being inexpensive is very important in this project as 
the problem statement itself requires a low-cost system. 
 
Figure 10 – Sub-objectives for Objective D 
Prototype costs less than $450 (Objective D1, 40%) 
$450 is the allocation we had for the whole project and so in building this system, we need to 
stay within that budget. Decreasing the complexity of a system (by using fewer, simpler 
components) may decrease the expense of it. Higher scores are assigned to alternatives that are 
more likely to stay within the budget when produced and used in a study.  
Completion within given time and available resources (Objective D2, 60%) 
There were approximately 8 months available to complete this project. It was of paramount 
importance that we meet that target in order to consider the project a success. After considering 
all that needs to be done (i.e. ordering parts, assembling and synthesizing components, testing the 
system), systems that seem likely to take less time for development get assigned a higher score. 
Alternative Designs 
After establishing the objectives of the design project, and the relative importance of each, we 
generated a list of ideas to fulfill the objectives. They are presented in this section. 
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Microphone 
This design consists of an acoustic microphone positioned on or slightly above the surface of the 
chest. The microphone would serve as a substitute for the traditional stethoscope in that it would 
record the sounds normally heard by users of the stethoscope. The microphone used would be 
able to detect sounds at the frequency and amplitude of those produced by the lungs during 
breathing, specifically wheezes and crackles, two adventitious lung sounds produced by 
pulmonary disorders. 
The microphone’s analog output would be amplified, converted to a digital signal, and input to a 
computer system. The computer would determine the frequency content of the lung sound signal, 
or otherwise process the sound to determine information about the occurrence and time of 
adventitious lung sounds. This information, when compared to a standard recording, is used to 
generate a diagnosis. An illustration of the system is shown in Figure 11. 
 
Figure 11 – Microphone Design Alternative 
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Vibration Sensor 
This design consists of a strap wrapped tightly around the chest. Any vibrations that occur in the 
lungs during respiration would be recorded by a sensor in this strap. (Such sensors are known as 
accelerometers, as they also measure acceleration.) These vibration signals would be amplified 
and digitized, and then passed to a computer. Software would detect each vibration event, and 
annotate each event. The sequence of vibrations would be compared and contrasted with 
vibrations recorded from patients known to have the disorder, and the diagnosis could be 
generated from that comparison. An illustration of the system is shown in Figure 12. 
 
Figure 12 – Vibration Sensor Design Alternative 
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Cough Detection 
The cough is a lung sound that has been used for a long time for diagnosis, but mainly 
interpreted by ear by a physician during auscultation. It is also known that there are some 
respiratory abnormalities that will cause someone to have a particular kind of cough (e.g. dry). 
These differences are very subtle to the ear, either trained or not. Digital capture of the cough 
sound may allow analysis and detection of important differences specific to particular 
abnormalities (asthma and pneumonia). An easy, low-cost way to do this is to have patients 
cough into a microphone and have the sound detected from either the mouth or the throat. This 
sound could then be processed in hardware and software, and analyzed digitally.  
A representation of the system is shown in Figure 13. 
 
Figure 13 – Cough Detection Design Alternative 
A problem that could arise with this system, especially if the sound is being detected from the 
mouth, is having such high intensity of air flow into the microphone. The problem with this 
could be that the sound would be too explosive to detect any helpful detail in the sound. A better 
system could still utilize the microphone, but have a barrier that would efficiently transmit the 
sound, but block the explosive air flow from the mouth. A representation of this new system is 
shown in Figure 14. 
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Figure 14 – Cough Detection Design Alternative with Air Blocking Barrier 
This second system seems to be the better out of the two to consider in choosing a potential final 
design.  
Air flow Detection 
Another indication of disease may be a certain pattern of air flow, either from someone coughing 
or someone blowing as hard as they can into the apparatus. The assumption is that different 
respiratory abnormalities will cause people to have different air flow rates when coughing or 
blowing. They may have decreased flow rates if they are suffering from an ailment, and perhaps 
different reductions are characteristic of particular abnormalities. One technique could be to 
determine pressure differentials and extrapolate the air flow velocity. The apparatus would be 
divided into numerous smaller pipes to eliminate turbulence and ensure laminar air flow where 
the pressure is being measured. A pressure transducer would used, in conjunction with hardware 
and analysis software.  
A representation of the system is shown in Figure 15. 
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Figure 15 – Air Flow Detection Design Alternative 
The apparatus could also be set up so that the path of air flow would have a turbine that would 
have an audometer or a similar device to determine the speed of the air passing through. In this 
case, other factors and parameters such as the torque of the turbine would need to be considered. 
A representation of the alternate system is shown in Figure 16. 
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Figure 16 – A Second Air Flow Detection Design Alternative 
Combination Design 
A system could be made with a combination of the two parameters; sound and air flow. A 
microphone could be embedded into the air-flow apparatus. A representation of the system is 
shown in Figure 17. 
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Figure 17 – Combination Design Alternative 
Drug-Induced Response 
Another diagnostic technique is the intentional administration of an agent to a patient to produce 
a mild constriction of the airways. The most common drug used in this procedure is 
methacholine, which affects asthma patients. After the drug is administered, vital signs are 
monitored and a diagnosis deduced from the patient’s response, which can be seen generally 
between twenty and forty-five minutes. Some protocols for rapid testing exist, which allow 1the 
doctor to administer a similar test in approximately fifteen minutes. 
The analysis of the patient’s response can include air flow measurements, auscultation, and 
blood pressure or pulse measurements. In the case of a strong asthma condition, a bronchodilator 
can be administered after the test results are obtained to return the patient to a normal state. 
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An illustration of this alternative is shown in Figure 18. 
 
Figure 18 – Drug-Induced Response Design Alternative 
Although the testing is by large harmless, there are some side effects. The patient will likely 
experience augmented symptoms of the lung disease (wheezing, coughing, and shortness of 
breath) during or immediately following testing. These symptoms can usually be cleared with the 
use of a bronchodilator. 
Possible complications include a slight risk of collapsed lung in some patients with acute lung 
disease. One of the problems with drug induced tests is that adverse effects may occur hours 
after testing. Accordingly, such tests should only be done in limited, specific circumstances, and 
then only under close and careful supervision by a doctor or specially trained technician. 
Respiratory Imaging 
Respiratory imaging methods – such as digital tomographic x-rays, CT-scan, MRI, and normal x-
ray imaging – are common for confirming a respiratory disease diagnosis, especially in 
questionable cases. The patient’s chest cavity is photographed and various discolorations can 
indicate inflammation or fluid build up in the lungs. A strong drawback of imaging is the fact 
that it may not accurately detect pneumonia at early stages, especially if the patient is dehydrated 
at the time of the test. Imaging can also be prohibitively expensive, particularly when used in the 
clinic as a screening tool. Typical imaging techniques take 1 to 15 minutes. 
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Respiration 
Auscultation 
Blood pressure 
Pulse rate 
Bronchodilator 
30 min 
 49
The average analysis time, however, is one to two days because a radiologist is often involved; 
he reviews the images and sends a report back to the doctor’s office. 
 
Figure 19 – Imaging design alternative, showing x-ray imaging as an example 
[x-ray courtesy of BBC News] 
The procedure is non-invasive. For some types of imaging, a small dose of radiation is 
administered to the patient, but the level is low enough to be benign unless many images are 
taken successively. The procedure is very common – it ranks among the most popular of all 
clinical diagnosis tests. 
Choosing Between Alternative Designs 
Each design alterative was analyzed in terms of how well it met the objectives previously 
established (on a scale of 0 to 5, with 0 being worst and 5 being best). The scores were 
multiplied by the weighting of the objective to calculate a total score for each design. The use of 
this method ensured that the choice was completely objective. Table 7 shows this step. 
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Table 7 – Using Weighted Objectives to Select Design from Alternatives 
 Design Alternative: Microph. Chest Str. Cough Air flow Drug-Ind. Imaging
35% Gives correct diagnosis 3.25 3.25 2.15 2.65 2.80 4.75 
40% Agrees with accepted values 3 3 3 3 4 5 
25% Reproducible 4 4 1 3 2 4 
35% Reliable 3 3 2 2 2 5 
        
10% User Friendly 4.20 4.20 3.20 3.60 2.00 2.20 
60% Intuitive output of data 5 5 4 4 2 3 
40% Fast analysis 3 3 2 3 2 1 
        
20% Patient Friendly 4.85 2.40 4.00 3.50 2.40 2.90 
30% Able to be sanitized 5 2 4 4 5 4 
35% Doesn’t harm user 5 3 4 3 1 3 
15% Non-frightening 4 1 4 3 1 3 
20% Small and light 5 3 4 4 2 1 
        
35% Inexpensive/ simple 4.40 3.00 3.40 3.60 2.00 1.00 
40% < $450 5 3 4 3 2 1 
60% Completed within given time 4 3 3 4 2 1 
        
 Overall Score: 4.07 3.09 3.06 3.25 2.36 2.81 
 
All scores were assigned following in-depth research on the specific diagnostic method. In order 
to presume impartiality and validity of the best alternative selection, score justification for each 
individual design in each scoring category is outlined below.  
Microphone 
35% Gives correct diagnosis 3.25 
40% Agrees with accepted values 3 
Because it has never been tested, it is difficult to give this method the highest score. 
However, it is known that sounds are produced by the lung, and that these sounds are 
related to the pulmonary pathology; therefore it should be a viable method. 
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25% Reproducible 4 
Because sounds are fairly straightforward to collect, and unusual lung sounds will persist 
for some length of time, it is likely that repeating the acquisition and analysis will give an 
identical diagnosis. 
35% Reliable 3 
As the equipment is simply a self-contained microphone connected to an analog-digital 
converter, there should be little room for malfunction. However, the final product has not 
been designed, and it is possible that the system could have a weakness. 
10% User Friendly 4.20 
60% Intuitive output of data 5 
The system would allow the care provider to both view and hear the data collected, as 
well as monitor each step of the process if desired. The analysis and diagnosis are 
displayed clearly and automatically. 
40% Fast analysis 3 
After the data collection, the software analysis should be quick, as it is likely that digital 
audio filtering and manipulation – fast operations on modern processors – will play a 
large part in the analysis. However, because the analysis is not yet fully implemented, the 
amount of time it takes is unknown. 
20% Patient Friendly 4.85 
30% Disposable/Able to be sanitized 5 
Just like the modern stethoscope, a microphone can be quickly wiped clean with an 
ethanol solution, for easy cleaning. 
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35% Conforms to regulations/doesn’t harm user 5 
Since the microphone is simply placed on the chest and used to collect sounds, normal 
usage poses insignificant risk to the patient. 
15% Non-frightening 4 
Again, the microphone is placed on the chest, and few patients would consider this 
frightening. However, young patients do find the traditional stethoscope cold and 
frightening, so the same could be thought of a microphone. 
20% Small and light 5 
The component that comes in contact with the patient is a small microphone. The 
analysis equipment consists of a personal computer – which could easily be a portable 
computer – that can be moved without difficulty from room to room if necessary. 
35% Inexpensive/ simple 4.40 
40% < $450 5 
A prototype can be developed with no materials beyond a microphone that can be 
acquired for less than $450, and computer equipment currently available for our use. 
60% Completed within given time 4 
With the design team’s expertise, we will have no problem developing an algorithm by 
the completion deadline. 
Vibration sensor: 
35% Gives correct diagnosis 3.25 
40% Agrees with accepted values 3 
Because it has never been tested, it is difficult to give this method the highest score. 
However, it is known that vibrations are produced by the lung, and that these vibrations 
are related to the pulmonary pathology; therefore it should be a viable method. 
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25% Reproducible 4 
Because the vibrations are fairly straightforward to collect, and will be affected similarly 
by disorders, recording and analyzing data from the same patient, during the period when 
the disorder is in the same stage, should give an identical diagnosis. 
35% Reliable 3 
The equipment is not only a vibration sensor, but also a chest strap attachment that needs 
to be oriented properly and moved and adjusted a great deal. Malfunction seems to be an 
unfortunate possibility. 
10% User Friendly 4.20 
60% Intuitive output of data 5 
The system would allow the care provider to view the data collected, as well as monitor 
each step of the process if desired. The analysis and diagnosis are displayed clearly and 
automatically. 
40% Fast analysis 3 
After the data collection, the software analysis should be quick, as it is likely that digital 
signal filtering and manipulation – fast operations on modern processors – will play a 
large part in the analysis. However, because the analysis is not yet fully implemented, the 
amount of time it takes is unknown. 
20% Patient Friendly 2.40 
30% Disposable/Able to be sanitized 2 
A chest strap needs to be included that holds the vibration sensor in place and conducts 
vibrations from areas throughout the thorax. It will not be easy to clean, and needs to be 
securely attached to the vibration sensor, so a disposable strap is not an option. 
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35% Doesn’t harm user 3 
It is possible that the conducting and securing straps could be adjusted improperly, and 
thus be able to injure the patient. 
15% Non-frightening 1 
Having a large apparatus attached to oneself could very well be frightening. 
20% Small and light 3 
Parts of it are small and light, but the assembly needed to conduct the vibrations is 
relatively large and obtrusive. 
35% Inexpensive/ simple 3.00 
40% < $450 3 
This alternative design not only requires an accelerometer (vibration sensor), which 
should be within the budget, but also an assembly to hold it and conduct the sound. 
60% Completed within given time 3 
Current research has been done on lung sound propagation and analysis, but to study lung 
vibrations, and use them as a basis for diagnosis, could take much additional work. 
Cough: 
35% Gives correct diagnosis 2.15 
40% Agrees with accepted values 3 
Signals from coughs are not used much and, when compared to other signals obtained 
using microphones (such as having a specialized microphone placed on the chest), the 
signal obtained is not very clear. There isn’t a standardized way of diagnosis from 
analyzing cough waveforms, and rudimentary techniques have not yet been very carefully 
assessed.  
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25% Reproducible 1 
Coughs in themselves are not particularly reproducible, and they are less likely to be 
reproducible in a manner that would make them distinguishable for ailments with similar 
symptoms. Cough characteristics do not only vary from individual to individual, but may 
vary from cough to cough in the same individual. This may create a big challenge for the 
consistent analysis by this system. 
35% Reliable 2 
The system may be good at detecting and analyzing sound that it receives, but with the 
very high density of sound that can be captured by the microphone from a cough, it may 
be difficult to coerce a system to be able to give a diagnosis without complex functions. It 
makes it less reliable when the parameter being measured is less reproducible than most. 
10% User Friendly 3.20 
60% Intuitive output of data 4 
When a cough sound is made and represented digitally, cough identification is not 
difficult. Analysis of the finer details of the cough may be less simple for the user to 
understand, however. 
40% Fast analysis 2 
With respect to determining the number of coughs per episode and the number of 
episodes, that would be quite easy to count. However, to get to that point, a lot of time 
would need to be spent monitoring the patient. Given the explosive nature of the output 
signals obtained, more complex techniques would need to be used to analyze a single 
cough signal. 
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20% Patient Friendly 4.00 
30% Disposable/Able to be sanitized 4 
Contact between patients and the system is not necessary and this could be interpreted as 
being safer for the patients. However, the symptom of which the measurements are made 
(coughing) is one of the most common ways pathogens are spread, so the system needs to 
be carefully sanitized. It should not be difficult to sanitize, however. 
35% Conforms to regulations/doesn’t harm user 4 
The system does not require any contact between the patient and the instrument; therefore 
the patients are not susceptible to much harm from it. 
15% Non-frightening 4 
The part of the system that the patients would interact with, the microphone, does not 
seem harmful or frightening. 
20% Small and light 4 
The system does not require too much equipment - only a microphone with an air flow 
barrier, and a computer for analysis. 
35% Inexpensive/ simple 3.40 
40% < $450 4 
A prototype can be built while staying within the $450 budget. 
60% Completed within given time 3 
It is very possible to complete the project within the given time with this system. 
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Air flow: 
35% Gives correct diagnosis 2.65 
40% Agrees with accepted values 3 
Physiological measurements of air flow have been done extensively, but analyses done 
with only air flow measurements do not seem to have been very common. It is not known 
how well this system would produce these analyses and the subsequent diagnosis. 
25% Reproducible 3 
The measurement of air flow is reproducible, but there is much variation/variability in the 
parameter being measured and this could adversely affect the results given by the system. 
35% Reliable 2 
Measurement of air flow is relatively easy, but an analysis and diagnosis only based on 
air flow would probably not be very accurate and thus not very reliable. 
10% User Friendly 3.60 
60% Intuitive output of data 4 
The air flow can easily be measured and displayed. 
40% Fast analysis 3 
The measurements can be done in real-time, but we are not sure how fast it is to analyze 
and have a diagnosis output from the system. It seems like the analysis would be done in 
a reasonable amount of time. 
20% Patient Friendly 3.50 
30% Disposable/Able to be sanitized 4 
The system can be sanitized and a part of it, the mouthpiece cover, is disposable. 
35% Conforms to regulations/doesn’t harm user 3 
The system does not seem to have anything that could adversely affect the patient. 
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15% Non-frightening 3 
Having to blow through a tube and causing shortness of breath may be disconcerting for 
some patients. 
20% Small and light 4 
The system is reasonably small and light, including the handheld part, the transducers, 
and the computer system. 
35% Inexpensive/ simple 3.60 
40% < $450 3 
This system could be built within the budget allocation. The pressure transducers would 
be the most costly component, as we have computers available for use. 
60% Completed within given time 4 
Construction of the system can be completed in given time period. 
Drug-induced response: 
35% Gives correct diagnosis 2.80 
40% Agrees with accepted values 4 
This method is currently used by clinicians on a small percentage of all patients to 
confirm hard to make diagnoses. It is widely accepted as valid within the professional 
community and serves as a valid diagnostic tool. 
25% Reproducible 2 
Patients’ response strongly depends on the amount of the agent inhaled and the effort put 
forth by the patients to express the symptoms of the pulmonary disorder. Also, bronchial 
tone is increased during the test, thereby altering the patients’ normal breathing pattern. 
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35% Reliable 2 
This method only causes a diagnosable response in a small part of all patients and 
therefore is not universal. 
10% User Friendly 2.00 
60% Intuitive output of data 2 
Test results are highly interpretive and do not always lead to an unambiguous diagnosis. 
Patients’ responses are expressed by many various parameters and are fairly difficult to 
interpret. 
40% Fast analysis 2 
Additional tests are required to propagate the drug induced response into a diagnosis. 
Also, some symptoms of severe pulmonary disorders do not occur until a few hours after 
the test. 
20% Patient Friendly 2.40 
30% Able to be sanitized 5 
Drug is administered to the patients through a specialized inhaler, which can be 
disposable. Alternatively, the small inhaler can be easily sanitized. 
35% Doesn’t harm user 1 
Drug administration is potentially dangerous for patients with severe lung disorders. 
15% Non-frightening 1 
The test is meant to produce a bronchospasm, a disease response, from the patient which 
is not pleasant.  
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20% Small and light 2 
This test requires multiple equipment pieces, some of which are quite large and 
immobile. 
35% Inexpensive/ simple 2.00 
40% < $450 2 
The equipment and the need for a supply of medication make this method costly. 
60% Completed within given time 2 
Drug admission to patients is certainly beyond the scope of this project. 
Imaging: 
35% Gives correct diagnosis 4.75 
40% Agrees with accepted values 5 
Imaging is one of the most common diagnostic tools used in the field today. 
25% Reproducible 4 
Lungs can appear slightly different from one image to another; the variance can be due to 
the momentary condition of the person or instantaneous lung volume. 
35% Reliable 5 
With proper analysis (by a well trained and experienced professional), imaging can reveal 
much information about the lung condition. 
10% User Friendly 2.20 
60% Intuitive output of data 3 
Images must be interpreted and the diagnosis may vary among professionals. High level 
of skill is required to analyze the results. 
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40% Fast analysis 1 
Professional opinion of a radiologist is necessary for complete diagnosis. Turnaround 
time depends on where the radiologist is, but nonetheless requires sending information 
out of the office and waiting for a response. 
20% Patient Friendly 2.90 
30% Able to be sanitized 4 
No contact is made with the patient by the machine itself. Often some shielding has to be 
worn to prevent unnecessary exposure to radiation, but skin contact is minimal. 
35% Doesn’t harm user 3 
For some types of imaging, a small dose of radiation is administered. Even though the 
amount is too minute to produce harmful effect, multiple screenings multiply the risks. 
15% Non-frightening 3 
The imaging machines are fairly large and the amount of precautions that must be taking 
during some types of imaging can make a patient uncomfortable. 
20% Small and light 1 
Imaging equipment is large and hardly mobile. 
35% Inexpensive/ simple 1.00 
40% < $450 1 
Imaging machines and film development equipment (when necessary) are extremely 
expensive. 
60% Completed within given time 1 
Using this type of equipment is beyond the scope of this project. 
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Figure 20 – Block diagram of Microphone System Design 
After formally selecting the microphone design, a detailed design was created. A block diagram 
is shown in Figure 20. The design of both the hardware and the software stages of the system are 
detailed below. 
Hardware Design 
The first generation of the hardware design used a miniature microphone (Star Micronics MAA-
03A-L back electret condenser microphone) together with a driving circuit suggested by the 
manufacturer’s datasheet (Figure 21), amplified by a simple one-stage amplifier. The signal was 
fed into a computer sound card’s microphone port and recorded by an open-source software 
package called Audacity (http://audacity.sourceforge.net/). 
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Figure 21 – Early hardware circuit design 
The first set of tests focused on establishing the basic function of the assembled microphone 
prototype. Speech, whistling, and musical scales were successfully recorded and reproduced on 
the computer. During these tests the microphone was positioned at distances from the sound 
source ranging from only a few centimeters to approximately fifty centimeters. The sensitivity of 
the microphone circuit was acceptable: sounds played back on the computer exhibited little 
distortion from the live events. The microphone did, however, pick up the noises due to air 
passing directly over the pick up head; this unwanted noise was specifically noticeable during 
whistling close to the microphone. 
Once we established our prototype’s basic functionality, an attempt was made to couple the 
device with a stethoscope and record some pulmonary sounds. We placed the microphone into 
the most easily accessible part of the stethoscope, the earpiece. In theory, the sounds recorded by 
the system in this configuration would be identical to what a physician would hear by using the 
stethoscope in the traditional way. Our prediction was that sounds recorded by the prototype 
device would be of smaller amplitude than speech or whistling. Unfortunately, the system turned 
out to be completely insensitive to pulmonary sounds. The inability of the prototype to detect 
breathing sounds was attributed to the relatively low quality of the components used and to the 
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simplicity of the system. Figure 22 contrasts the recordings of the different types of sounds 
through the stethoscope. 
(a)  (b)  
Figure 22 – Whistling sound (a) and breath sound (b) recordings made through stethoscope. 
Despite the device’s inability to detect pulmonary sounds, the process of building a prototype 
was successful in some ways. The experience of working with the microphone hardware led to 
the conclusion that a better design would use an integrated, commercially-available hardware 
package, allowing the focus of the development period to be spent on software design.  
In the final design, the hardware stage consisted of a physiological sound microphone (BIOPAC 
TSD108) connected to a differential amplifier module (BIOPAC DA100B) and a data acquisition 
unit (BIOPAC MP100). This system was specifically designed to digitize physiological sounds, 
and included appropriate filters and analog-to-digital converters. Users also have the option to 
monitor the audio recording with a headset (the volume is adjustable with a knob). 
Minimizing the noise detected by the microphone was a challenge, even with the commercial 
microphone package. Several modifications to the basic design were attempted: 
• A foam padding shell was fabricated and the microphone was placed inside. This was 
intended to provide insulation from both room background noise and from any undue 
motion of the user’s hands when holding the microphone. This modification was rejected, 
as the foam would have been in contact with the patient, and would have posed a 
sanitation risk. The foam padding is shown in Figure 23. 
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Figure 23 – Foam padding shell 
• An ultrasound conducting gel was used in between the patient and the microphone, in the 
hope that the lung sounds would be transferred more accurately from the skin surface to 
the microphone. This was messy, unfortunately, and did not significantly affect the 
fidelity of the recorded lung sound. 
• A rubber cylinder was affixed to the back surface of the microphone. This muffled much 
of the user motion, and did not come in contact with the patient, so sanitation was not an 
issue. This modification was implemented in the final design. Figure 24 shows this 
cylinder attached to the microphone. 
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Figure 24 – Rubber cylinder handle on microphone 
The final hardware acquisition system is shown in Figure 25. 
 
Figure 25 – Final hardware design in clinical setting 
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The BIOPAC A/D converter interfaces with a computer, and is controlled by BIOPAC®’s 
proprietary AcqKnowledge™ software (Version 3.7.3). This software acquires the sounds, which 
are then saved to disk in plain text data files. The software design section below describes the use 
of software to analyze these recorded sounds. 
Software Design 
Analyzing the lung sound signals digitally permits the use of an unprecedented number of 
analytical tools. Using MATLAB® (Version 7.0.1), the system is able to extract useful features 
from the lung sound recordings and use them to differentiate between healthy and diseased 
breathing patterns. In addition to producing an audible output like that of a conventional 
stethoscope, the system is capable of generating a visual representation of the processed data, 
called a spectrogram. A spectrogram of the sound of a healthy lung is shown in Figure 26. The x-
axis represents time, the y-axis represents frequency, and the color represents the intensity of 
each sound frequency at each time in the recording. The breathing pattern is discernable, as is the 
fact that there are a few narrow bands of high frequency noise. 
 
Figure 26 – Spectrogram of a generally healthy lung sound 
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Since asthma and pneumonia should be diagnosable by the relative amounts of wheezing and 
crackling (respectively), algorithms were developed to detect each of these adventitious sounds.  
Crackle Detection 
A spectrogram of a lung sound recording exhibiting crackles is shown in Figure 27. Crackles, as 
discussed in Chapter 2, are high-intensity, high-bandwidth noises lasting between 10 and 20 ms. 
Crackles are represented in the spectrogram as vertical red lines, and points at which crackles are 
detected are shown in white in the black band above the spectrogram.  
 
Figure 27 – Spectrogram exhibiting lung sound crackles 
The algorithm functions by first creating a spectrogram. The overall intensity of the image is 
found, and a threshold is calculated. A filter is then used to remove all parts that are less intense 
than that threshold, as well as those outside the established frequency band of 200 to 1500 Hz 
(the frequency range in which crackles occur). Another filter then removes all components of the 
signal that do not have a bandwidth of at least 900 Hz. The procedure counts crackles in the 
remaining data by incrementing over time and searching for signals that last from 10 to 20 ms. 
The final step of the crackle detection algorithm is to create a crackle ratio, which is the 
percentage of the recording that contains crackles. 
A flowchart is shown in Figure 28. The code for this algorithm, implemented in MATLAB, can 
be seen in Appendix C. 
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Figure 28 – Flowchart of Crackle Detection Algorithm 
 70
Wheeze Detection 
A spectrogram of a wheezing lung sound is shown in Figure 29. Wheezes, as discussed in 
Chapter 2, are continuous, low-bandwidth, longer-lasting noises. The horizontal orange-red areas 
in the spectrogram are wheezes. Detected wheezes are shown in white in the black band above 
the spectrogram. 
 
Figure 29 – Spectrogram exhibiting lung sound wheezes 
Portions of the wheeze detection algorithm were modified from a method proposed by Shabtai-
Musih et al (634). Like the crackle-detection program, this algorithm functions by first 
generating a spectrogram. The procedure then increments over time, searching for local maxima 
in the frequency domain at each time point. The prominence of each maximum is found by 
comparing its intensity to the intensities of neighboring frequencies. Trails of these maxima 
represent potential wheezes. The length and prominence of each trail is then calculated, and 
wheezes are detected when the length and prominence reach a threshold. The final step of the 
wheeze detection algorithm is to create a wheeze ratio, which is the percentage of the recording 
that contains wheezes. 
A flowchart is shown in Figure 30. The code for this algorithm, implemented in MATLAB, is in 
Appendix C. 
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Figure 30 – Flowchart of Wheeze Detection Algorithm 
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Spatial distribution of measurements  
When the system is in use, lung sounds from approximately two full breaths are recorded at each 
of six locations on the subject’s back. The locations are numbered 0 through 5 (Figure 31). This 
auscultation pattern is commonly used by physicians and allows for spatial differentiation of 
lung sound data. This spatial distribution is a significant constituent of the asthma and 
pneumonia scores and thus, the final diagnosis algorithm.  
There is one exception to this procedure – when the lung sound data is collected from infants, 
only four recording locations are used. It has been found that there simply is not enough space on 
the child’s back to reasonably make six different recordings. The diagnosis algorithm is slightly 
modified as necessary to accommodate these nonstandard recording patterns. 
 
Figure 31 – Six locations of recorded lung sounds 
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Pneumonia and Asthma Score Assignment 
The second and final stage of the software design involves the calculation of “scores” (similar to 
those generated by Murphy et al, 2004) for both asthma and pneumonia. The pneumonia score 
consists of the mean of the crackle ratios from each recording multiplied by the standard 
deviation of these ratios. This gives a higher pneumonia score to those who demonstrate 
localized problems, and a lower score to those whose problems are non-localized. 
The asthma score consists of the mean of the wheeze ratios from each recording divided by the 
standard deviation of these ratios. This gives a higher asthma score to those who demonstrate 
uniform pathology. 
These values are normalized to a scale of 0 to 10, in order to facilitate comparison between the 
pneumonia and asthma scores. 
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PART II – METHODS AND RESULTS 
CHAPTER 5 – METHODS 
Following the design stage of the device and building a working prototype, a method for 
validating the final product was developed. To assess the functionality of the device, the 
following hypothesis was proposed: 
The prototype device can detect adventitious lung sounds and distinguish between 
asthma and pneumonia symptoms. 
Initially, this hypothesis was tested using freely available lung sounds recordings from the 
R.A.L.E. Repository (R.A.L.E. “Adventitious Sounds”). It is necessary to note that the first 
version of the algorithm for abnormal sound detection was based on the characteristics of some 
R.A.L.E. sound recordings. To test the hypothesis and validate the device, the algorithm was 
applied to recordings from the repository. The results were promising: crackles and wheezes 
were consistently identified. Since the R.A.L.E. recordings were not originally acquired through 
the hardware of our prototype, only the software portion of the device was validated in this 
section. 
To validate the hardware portion of the device, as well as the ability of the software to analyze 
data recorded from this hardware, recordings from volunteers were collected. The first attempts 
to record lung sounds with the BIOPAC® hardware were carried out on the authors of this 
document. At first, a considerable amount of background noise was admitted into the recording. 
Various methods of noise reduction were proposed and implemented as described in the design 
chapter. 
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Clinical trial 
In order to collect data necessary for optimization of the analysis algorithm and device 
validation, a clinical trial was conducted at a local branch of Fallon Clinic. The project sponsor, a 
pediatrician from the clinic, provided us with this ideal setting for the trial. While the primary 
purpose of the trial was to verify the main functionality of the system (i.e. to detect adventitious 
lung sounds and generate a diagnosis), the trial also provided us with invaluable feedback for our 
lung sound acquisition hardware and software designs, as the system was steadily used by 
doctors, nurses, and patients. 
In order to gain approval for this trial, much preparatory work was done in efforts to adhere to 
Fallon Clinic’s, as well as general, health practice policies and regulations. As a prerequisite for 
visiting the clinic and observing the pediatrician’s work, we underwent training regarding 
Protected Health Information (PHI) and confidentiality agreements. 
A Summary Form was completed, indicating the intentions, technicalities, and logistics of the 
study. Consent and Assent Forms were created for potential subjects in the trial. Because it was 
anticipated that most subjects would be minors, a parent or guardian was required to complete 
the Consent Form, while completion of the Assent Form was required for each subject. The 
study was approved by the Institutional Review Board (IRB) of Fallon Clinic. The IRB from 
Worcester Polytechnic Institute accepted the same forms. All three forms can be found in 
Appendix A. 
The trial ultimately included 45 patients between the ages of 0 and 19. The device was brought to 
the clinic and was used for 2 months, the duration of the clinical trial. Data was periodically 
downloaded for analysis outside of the clinic. 
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Figure 32 – Clinical trial setup 
Doctor Thomas Eder was the primary investigator for this clinical trial and was responsible for 
subject recruitment as well as recording the lung sounds. Figure 32 demonstrates the setup of the 
sound recording process as performed during the clinical trial. Dr. Eder maintained a journal for 
this study where he noted the diagnosis of each patient in the study. (This diagnosis was made 
based on the normal methods for diagnosing respiratory disorders, such as auscultation and x-ray 
imaging.) The recordings made were used first in detection algorithm development and later to 
test the device’s diagnostic ability. 
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CHAPTER 6 – RESULTS AND ANALYSIS 
The clinical trial provided invaluable feedback to the design process, in that the hardware and 
software could be tested in an environment very close to that in which it was designed to 
function clinically. Results were obtained for each of the major components of the design: 
hardware and software. 
Hardware 
Both the user (Dr. Eder) and the patients responded positively to queries regarding the ease of 
use and the patient-friendliness of the hardware design. Although there was no formal survey of 
the user perception involved in the study, the anecdotal data obtained indicate that users are 
satisfied with use of the system at the hardware level. Dr. Eder did not wish to use the included 
headset to monitor his recording, as he found it uncomfortable. (He did, however, auscultate each 
patient by stethoscope for the purposes of his own diagnosis.) 
The functionality of the hardware system was also tested, although again not formally. Each of 
the recordings was reviewed both audibly and visually using a spectrogram. Little noise was 
found, and any that was present was generally at the very beginning or end of each recording, 
when Dr. Eder was presumably adjusting the position of the microphone. There was no evidence 
of amplitude clipping of the recorded signal, with the exception of two recordings where the 
infant subjects began crying, a sound which the system was not designed to record or analyze. 
Dr. Eder also took part in reviewing several recordings, and noted that the recordings were 
accurate and similar to his stethoscope auscultation findings to the extent that he could recall.  
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Software 
The raw recordings, as well as the results of the software analysis, are included in the 
accompanying CD. A sample recording and algorithm results from each class of patients are 
included and depicted schematically in Figure 33 (pneumonia), Figure 34 (asthma), and Figure 
35 (normal respiratory health).  
 
Figure 33 – Results from subject 31 (diagnosed with pneumonia) 
  
  
   
   
 
 
Subject 31 – clinically diagnosed with pneumonia 
 
Wheeze mean: 0.0043 Crackle mean: 0.0087 
Wheeze STD:  0.0038 Crackle STD:  0.0099 
Asthma Score: 1.0116 Pneumonia Score: 4.4835 
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The spectrograms in each figure were generated from the recording produced in the section of 
the back in which the image is shown. Detected crackles are shown in white in the black bar 
above each spectrogram, and detected wheezes are shown in pink in the blue bar above each 
spectrogram. Calculated parameters are given below each group of spectrograms, and the bar at 
the bottom of each figure gives the asthma score (in red) and the pneumonia score (in blue). 
 
Figure 34 – Results from subject 8 (diagnosed with asthma) 
  
  
   
   
 
 
Subject 8 – clinically diagnosed with asthma 
 
Wheeze mean: 0.2378 Crackle mean: 0.0388 
Wheeze STD:  0.1270 Crackle STD:  0.0204 
Asthma Score: 9.2986 Pneumonia Score: 7.4537 
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Figure 35 – Results from subject 34 (no clinical diagnosis - healthy) 
The crackle and wheeze scores for each recording correlated well with qualitative judgments 
from Dr. Eder’s own auscultation, as well as visual scrutiny of the spectrograms produced. The 
locations of the crackles and wheezes detected also correlated with a visual estimation, as can be 
seen in the three sample results. 
  
  
   
   
 
 
Subject 5 – no clinical diagnosis - healthy 
 
Wheeze mean: 0.0109 Crackle mean: 0.0027 
Wheeze STD:  0.0220 Crackle STD:  0.0034 
Asthma Score: 0.5387 Pneumonia Score: 3.5086 
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The asthma and pneumonia scores were generated for each subject by the calculation discussed 
in the design chapter; the scores are shown in Figure 36. The correlation between the diagnostic 
scores generated and Dr. Eder’s qualitative diagnosis is much weaker than that for the detection 
stage of the software analysis. 
 
Figure 36 – Diagnostic scores. Red bars on the left are Asthma scores, blue bars on the right are Pneumonia 
scores. Central column identifies the study subject’s number. Numbers 1-4 and 26 were test runs, and were 
therefore not included. Subjects that were diagnosed with asthma are indicated by yellow boxes in the left 
column, and those diagnosed with pneumonia are boxed in yellow in the right column. 
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CHAPTER 7 – DISCUSSION AND CONCLUSIONS 
This project was successful in that the final device met many of the original objectives 
prescribed by the design process. The following summary will outline the specific objectives and 
how well the final device performed in each category. 
Correct diagnosis: 
• Agrees with accepted values 
This objective was not met completely by the current system. Although the detection 
algorithm was decidedly successful, many of the diagnostic scores generated by the 
system were not correlated to their associated clinical diagnoses. This casts doubt upon 
the initial assumption that the wheeze and crackle content of the lung sound can be used 
as the sole diagnostic tool for asthma and pneumonia. However, the most important 
contribution of this project to the field of pulmonary diagnostics was in the partial 
completion of this objective: the development and optimization of the algorithms to 
automatically recognize and classify various lung sounds. 
• Reproducible 
Due to the limitations of the study (each subject was only seen by the doctor once, during 
a regular office visit) this parameter was not tested. 
• Reliable 
During the two months spent in the clinical environment, the system did not show any 
signs of wear. This time period was as long as the study was able to run for; therefore, the 
reliability objective was met without reservations. 
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User friendly: 
• Intuitive output 
The spectrograms produced by the device require minimal explanation and allow much 
information to be presented in a simple visual form. The final diagnosis scores signify the 
severity or likelihood of asthma or pneumonia in every subject. The objective of intuitive 
output was successfully met. 
• Fast analysis 
Transfer of data from the acquisition system onto a computer with MATLAB® software 
is slightly time-consuming. Once the data have been transformed into a proper format, 
the analysis algorithm executes within seconds. Overall, the time required for the system 
to output a diagnosis is very reasonable compared to other methods currently available to 
a physician (i.e. x-ray imaging). 
Patient friendly: 
• Sanitizable 
The microphone can easily be sanitized. Alcohol wipes were used to clean the 
microphone during the clinical trial. 
• No harm 
There is no reason to suspect any harmful effects from use of the device. During the trial 
period, none of the 45 subjects were injured or otherwise harmed by the study. 
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• Non-frightening 
No patient complaints were noted during the time of the trial. Following proper 
explanations of the study through the Assent and Consent Forms, patients of the clinic 
were willing to participate and did not seem to be uncomfortable or frightened by the 
device. 
• Small and light 
The device has a personal computer as one of its components and the entire system was 
able to fit on a rolling cart (approximately 2 ft wide by 4 ft deep by 3 ft tall). A laptop 
computer could be used to significantly reduce the size of the system, but even in its 
current form, the system is easily moved from room to room. 
Inexpensive/simple: 
• < $450 
The total cost of this project was approximately $300. The majority of the cost was 
devoted to the purchase of the physiological microphone. The BIOPAC® equipment and 
the computer were borrowed from WPI, so the cost of those components is not included 
in the budget. The software used (AcqKnowledge® and MATLAB®) were also available 
through WPI. 
• 8 months 
The project began in September 2004 and was finished in April 2005, for a total duration 
of seven months (within the allotted timeframe). 
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CHAPTER 8 – RECOMMENDATIONS 
By filling a specific research niche and establishing innovative lung sound analysis methods, this 
project opens up opportunities for continuing research. The field of automated lung disease 
diagnosis is very young. At the date of this publication, the authors were not able to identify any 
commercial products and only one research group (Murphy et al.) making strong progress 
towards automated diagnosis. The majority of the project objectives have been met through its 
design and clinical testing components. This chapter offers suggestions for expanding the project 
to fully meet all objectives.  
A primary assumption (that the wheeze and crackle content of the lung sound can be used as the 
sole diagnostic tool for asthma and pneumonia) should first be re-evaluated. Although previous 
research has shown a correlation between adventitious lung sounds and specific respiratory 
disorders, it is possible that the correlation is not strong enough in some patients to serve as a 
primary indicator. After this step, future work should focus on algorithm improvements to the 
second stage (using the detected adventitious lung sounds to generate the diagnostic score). 
Follow-up studies can use the existing hardware and focus on improving the analytical 
component of the system. 
A significant improvement to the device would be performing the analysis in real time. This can 
be accomplished by eliminating incompatibilities between BIOPAC® and MATLAB® or 
implementing the entire process in a package such as LabVIEW® or MATLAB®. This project 
attempted to use LabVIEW® in the initial stages of software development, but due to lack of 
expertise and time constraints, a working interface for LabVIEW® was never developed. 
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Hardware improvements could be made to improve the acquisition of the lung sounds. Beyond 
simply using a more sensitive microphone, better physiological sound isolation methods could be 
developed. One possibility would be to use a directional microphone to isolate lung sounds from 
the background noise. Another alternative would be to implement active noise cancellation. 
These recommendations for changes in hardware would likely elevate the cost of the system 
significantly, but the cost may be tolerable if the performance of the system improves noticeably. 
To further validate the developed device and specifically the algorithm for diagnosis, a larger 
clinical trial should be conducted. There should be a shift from a young (infant to 19 years of 
age) population of the clinical trial to a wide range of ages, to validate the analysis and diagnosis 
capabilities of the system for a wider population. Also, it would be beneficial to the process of 
system optimization to have more subjects with pneumonia and asthma symptoms. An additional 
clinical trial could not only improve the design, but also improve the protocol used for recording 
lung sounds with the system. This would be helpful for any further use of the system, including 
any future commercial applications. 
Future researchers can also continue the use of the clinical data acquired from this trial. During 
the initial stages of this project, publicly available lung sound recordings were used to validate 
the system. Raw data from this study can serve the same training and validation purpose for 
future studies. There is a plethora of information in the lung sound recordings collected in this 
study. Future researchers may be able to apply their own analysis algorithms to the data, in the 
hope of improving the analysis system designed herein, or even to detect abnormalities and 
diagnose disorders not considered in this study. 
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As it stands, our project has proven to be successful in many respects, and the technique of 
pulmonary diagnosis based on automated lung sound analysis is a promising possibility for 
widespread use in the future. Implementation of our recommendations to improve our system, 
combined with other research currently being conducted in the field, will help automated lung 
sound analysis to become a useful and commonplace diagnostic tool, lowering the cost of 
accurate disease identification and reducing the number of diagnostic errors. 
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INFORMATION AND ASSENT FORM 
 
 
Study Name: Automated Stethoscope System 
 
Sponsor: Worcester Polytechnic Institute (WPI) 
 
Study Doctor: Dr. Thomas Eder 
191 May St. 
Worcester, MA 01602 
(508) 368-7887  
 
 
WHAT IS THIS STUDY ABOUT? 
 
Dr. Eder wants to find out if a system that uses a microphone and a sound recorder can help to 
see if someone has lung or breathing problems, such as asthma or pneumonia. Pneumonia is 
when germs in your lungs cause infection. This may make it hard to breathe. This is similar to 
what would happen if someone had asthma. So what will be done is called a “research study.”   
 
Your Mom, Dad or Guardian will read more about the study.  You can ask to read what the 
doctor gives them.  You should talk to your Mom, Dad or Guardian about the study. 
 
WHAT WILL HAPPEN TO ME IN THIS STUDY? 
 
If you want to be in the study, your doctor will record your lung sounds with this system as he 
usually does during your checkup.  He will place a microphone on different parts of your back in 
order to do this. This only takes about 5 minutes and it will only be done once. 
 
If you have any questions about what will happen to you in the study, you can ask your doctor or 
nurse.  If you do not want to do this, you can say you do not want to be in the study. 
 
 
DO I HAVE TO BE IN THIS STUDY? 
 
You do not have to be in the study if you don't want to.  If you say ‘Yes’ now, you can say ‘No’ 
and stop later if you change your mind.  No one will be angry with you if you say ‘No’.  The 
doctor will still take care of you. 
 
 
WHO CAN I TALK TO ABOUT THE STUDY? 
 
You can ask the doctor, your Mom, Dad or Guardian questions about the study any time.   
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ASSENT STATEMENT 
 
Please check one box: 
 
  Yes, I want to be in the study.   No, I do not want to be in the study. 
 
 
    
Name of Child (Print)  Date of Birth 
 
 
    
Signature of Child  Date 
 
 
    
Name of Parent or Guardian (Print)  Relationship to Child 
 
 
    
Signature of Parent or Guardian  Date 
 
 
  
Name of Person Explaining Assent (Print) 
 
 
    
Signature of Person Explaining Assent  Date 
 
 
PRINCIPAL INVESTIGATOR’S STATEMENT 
 
I attest that I or my representative discussed this study with the above named participant and 
parent/guardian.  This person had enough time to consider this information, had an opportunity 
to ask questions, and voluntarily agreed to participate in this study. 
 
 
    
Signature of Principal Investigator  Date 
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Patient Information and Informed Consent Form for electronic 
recording of lung sounds 
  
 
 
Study Name:  Automated Stethoscope System 
  
Sponsor: Worcester Polytechnic Institute  
Study Doctor: Thomas Eder, M.D.  
191 May Street 
Worcester, MA 01602 
 
Telephone:   (508) 368-7887 
 
You are being asked if you will approve your child’s participation in a research study using 
an experimental (not approved by the FDA) lung sound recording system.  It is your 
decision.  Your child will also be asked if they want to take part in the study.  You may 
decide to have your child in the study or he/she may not take part at all.  If your child takes 
part in the study, you may remove him/her from the study at any time.  In any case, your 
decision will not lead to any penalty or affect your child's regular medical care or any 
benefit to which your child is otherwise entitled.  If there is anything you do not understand 
about the study after reading this information, please ask your child's study doctor or 
study staff member. 
The purpose of this study is to help researchers find out if recording lung sounds using a 
specialized microphone and analyzing the sounds using a computer software system can 
significantly improve diagnosis through distinction between asthma and pneumonia. This 
study should not interfere with the traditional physical examination done by your child’s 
doctor. The traditional diagnosis techniques used in the physical examination are described 
below and will also be discussed with you and your child by your child’s doctor.  
Your child will be in this study for approximately the same amount of time as your child’s doctor 
would take using a traditional stethoscope, that is, about five (5) minutes. About sixty (60) 
patients at the Fallon Clinic, Inc. will be in this study; this will be the only site in the USA and 
Canada that will have patients participating in this study.    
 
 
What will happen if you and your child decide to be in this study: 
Your child's doctor will talk to you and your child about your child's health and give your 
child a physical exam.  Your child’s doctor will then listen to the child’s lung sounds using 
the lung sound recording system.  
Other Treatments  
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Asthma and pneumonia have very similar symptoms and, in addition to the doctor 
listening to lung sounds using the traditional stethoscope, many diagnoses need to be 
confirmed by X-ray pictures. It is hoped that this lung sound recording system will 
perform well enough to improve diagnosis without having to depend on X-rays as much. 
Benefits  
You and your child may not directly benefit from the study, but the hope is that distinction 
between asthma and pneumonia will be improved for the future. 
Risks  
There are no apparent risks for you or your child in this study. 
Compensation  
You will not be paid for taking part in this study. 
Questions 
Please feel free to ask any questions you may have about the study.   If other questions 
occur to you later, you may ask Dr. Eder at (508) 368-7887. If at any time, during or after 
the study, you would like to discuss the study or your research rights with someone who is 
not associated with the research, you may contact the Saint Vincent Hospital/Fallon 
Clinic/Fallon Community Health Plan Institutional Review Board at 508-595-2205. 
Confidentiality  
Your child's doctor will record your child's study information on forms and have information that 
will be sent to Worcester Polytechnic Institute. The study sponsor will use the information to 
continue research and to test the automated stethoscope system. By signing this informed consent 
form you agree to allow this review of sound recordings from your child. All records in which 
your child's name appears will be kept confidential.  Your child's name will never appear on any 
sponsor forms or in a report or publication. 
By signing this form I agree to the use of my child's personal data for the purpose described in 
this form.  
Study Funding  
There is no funding 
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Volunteer’s Statement 
 
? I voluntarily agree to my child's participation in this study. 
 
? I understand that the study sponsor, Worcester Polytechnic Institute, may stop the study at 
any time.    
 
? I have read and understand this statement of informed consent and the risks described. 
 
? I understand that I will receive a signed and dated copy of this consent form. 
 
? I understand that I may withdraw my consent or withdraw my child from this study at any 
time. 
 
? I have had a chance to ask questions and understand the answers given to all of my questions. 
 
? I understand I have not waived any of my legal rights by signing this form. 
 
______________________________________________________  ____________ 
Signature of parent, guardian                         Date 
 
 
______________________________________________________ 
Printed name of parent, guardian  
 
______________________________________________________ 
Relationship to study patient 
 
**************************************** 
 
______________________________________________________  ____________ 
Signature of person conducting informed consent discussion            Date 
 
 
______________________________________________________ 
Printed name of person conducting informed consent discussion 
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 SAINT VINCENT HOSPITAL/FALLON CLINIC/FALLON COMMUNITY HEALTH 
PLAN/ 
RESEARCH REVIEW COMMITTEE/INSTITUTIONAL REVIEW BOARD 
 
PROTOCOL SUMMARY SHEET FOR INVESTIGATIONS  
INVOLVING HUMAN SUBJECTS 
  
 
SECTION I 
(must be completed) 
TITLE OF PROJECT: 
 
Automated Stethoscope System 
 
Project #:  957 
 
SIGNATURES: 
 
Principal Investigator: _______________________________ Date: 
________________ 
Thomas J. Eder, M.D. 
 
SVH Or Fallon Liaison: ___________(none)_______________ Date: 
________________ 
 
(if not P.I.) 
 
 
Study Personnel Information: 
 
Principal Investigator  (include institution /address/ and telephone number):  
 
Thomas J. Eder, M.D. 
Fallon May Street Clinic 
191 May St. 
Worcester, MA 01602 
Phone: (508) 368-7887 
 
Name of all other Fallon or Saint Vincent Hospital personnel involved in the study (i.e. physicians, 
nurses and other research staff):  
Sandra White, RN 
Carol Magnsen, RN 
Kathy Elloian, RN 
Susan Skonieczny, RN 
Lisa Skog, RN 
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SECTION I 
(continued) 
 
 
 
Will residents, fellows, students, and temporary staff be involved in the study:  
__Yes___  _______          
      Yes      No 
If yes, what functions will they be performing? 
Students will install a lung sound recording system inside the clinic, and will collect the 
recorded data from the system for off-site analysis. The students do not anticipate being present 
during patient tests, but will train Dr. Eder to conduct the recording sessions. 
 
Who will be responsible for ensuring that they are all properly trained?   
Dr. Eder has already properly trained the students, and all procedural clearances have been 
arranged. 
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SECTION II 
(must be completed) 
 
 
PHI Status: 
 
Will “protected health information” be removed from Fallon Clinic/Saint Vincent Hospital/ 
Fallon Community Health Plan? (only employees are allowed to do this) to facilitate subject 
recruitment for this study?    No _No__ (skip to Section III) Yes _____  (If yes, you must 
complete the following).                                                             
List names of employees (and their departments) allowed to take PHI off premises: 
 
  
 
_______________________________________________________________________________
___________ 
 
 
_______________________________________________________________________________
___________ 
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SECTION III 
(must be completed) 
 
 
Description of Human Subjects: 
 
Describe how subjects will be initially identified.  How will they be contacted (letter, 
telephone, or in person) and by whom (and where, i.e., telephone interviewer from their 
home, physician, coordinator from Research Office…)? 
 
Study subjects will be recruited in person by Dr. Eder during regular office visits. 
 
Approximately how many at our site _60_ How many in total _60_ (nationwide) or _60_ 
(worldwide) 
 
Ages : 0 to 22 years 
  
 Source of patients: 
 
__X__ Fallon Clinic May St. Clinic – Pediatrics  
  and/or  
______Saint Vincent Hospital _____ dept.           
  and/or 
______clinic   ______inpatient 
 
______other (please elaborate)  
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SECTION IV 
 
Patient Consent:  
 
In order to use patient protected health information (PHI), staff must obtain a signed 
patient consent form with authorization (pre-approved by FC (Research Director) or SVH 
(CDRC)) attached, or receive a waiver by the IRB.   
 
If you will be using a consent form, please complete the following and proceed to 
Section V. 
 
Name of person(s) allowed to obtain consent:  Dr. Eder 
 
 
Will subjects include minors?   No__   Yes _X_ (A SEPARATE ASSENT FORM MUST 
ALSO BE 
        SUBMITTED)  
       
Do you plan to obtain surrogate consent if patient is unable to give consent?    No__X__ 
 Yes  ____       If yes; why do you feel it may be necessary to obtain surrogate 
consent/substituted judgment? 
 
If you will be requesting a waiver of Patient Authorization, please check here 
_____ ,  and read the following:   
The eligibility criteria for a waiver are: 
1) The research could not practicably be conducted without a waiver, and  
2) The research could not practicably be conducted without access to and use of PHI.  
3) The use and disclosure of PHI involves no more than minimal risk to the patient and 
privacy of individuals, based on, at least, the presence of the following elements: 
 i. An adequate plan to protect the identifiers from improper use and disclosure; 
       ii. An adequate plan to destroy the identifiers at the earliest opportunity consistent 
with  
conduct of the research, unless there is a health or research justification for 
retaining the identifiers or such retention is otherwise required by law; and 
iii. Adequate written assurances that the protected health information will not be 
reused or disclosed to any other person or entity, except as required by law, for 
authorized oversight of the research study, of for other research for which the use 
or disclosure of protected health information would be permitted 
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SECTION V 
(must be completed) 
Patient Information: 
1) Where will the data be recorded? 
Dr. Eder will record patient information in a password-protected electronic 
database, or in a personal notebook, not accessible to any other person. 
 
2) Please answer all of the following:  
 
i) Where will patient’s names be kept and who has access to these 
names? 
Names will be kept by Dr. Eder; only he will have access to them. 
 
ii) How will data be encoded?  (patient names, code number, patient 
initials?) 
Data will be encoded with a unique, arbitrary code number. Only Dr. Eder 
will have access to any privileged patient information (PHI).  
 
iii) Where will data be kept and who has access? 
Encoded, anonymous data will be kept digitally in the computer recording 
system and may be accessed by Dr. Eder and the rest of the research team. 
This data only includes digital lung sound recordings. 
 
iv) How will you protect the identifiers from improper use and 
disclosure? 
Only Dr. Eder will have access to any privileged patient information (PHI) 
or unique identifiers.  
 
If human subjects cannot be identified either directly or indirectly through 
identifiers linked to subjects, research is automatically eligible for a waiver and 
you may skip to section VI.  All others, continue. 
 
v) When will the identifiers be destroyed (must be the earliest 
opportunity)?   After all 60 have been enrolled.  At that time Dr. Eder 
will destroy the list of names. 
 
vi) What is the importance of this research? Explain.   To help 
differentiate between asthma and pneumonia 
 
Background and purpose of the study:  N/A 
 
Describe the plan (including how long you expect research records will need to be kept):   
N/A 
 
Principal Investigator will ensure that all staff with access to the PHI will abide by the 
following:  “No PHI collected for this research study will be reused or disclosed to any 
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other person or entity, except as required by law, or for authorized oversight of the 
research study.” 
 
______________________________________ _________ 
      Principal Investigator’s signature         Date 
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SECTION VI 
(must be completed) 
Plan of investigation:  
 
Please check off all types of PHI that will be collected: 
  
_X_ Name (known only to Dr. Eder – used only to prevent duplicate subjects) 
___Address (street address, city, county, zip code (more than 3 digits) 
_X_Birth date (known only to Dr. Eder – used only to prevent duplicate subjects) 
___Telephone number 
_X_Medical record number (known only to Dr. Eder – used only to prevent duplicate subjects) 
___*Names of relatives (must list reason needed) 
___*Names of employees  
___*Fax Number 
___*E-mail addresses 
___*Social security number 
___*Health plan beneficiary number account number 
___*Certificate/license number 
___*Any vehicle or device serial number  
___*Web url 
___*Internet protocol (IP) address 
___*Finger or voice prints 
___*Photographic images 
___*Any other unique identifying number, characteristics, or code (whether generally 
available in the public realm or not) 
 
*(must list reasons asterisked items are needed for study) 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
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SECTION VI (continued) 
 
Estimated start date:    March 14, 2005 
 
Time required to complete study:  1 Month 
 
 
Inclusion criteria (include additional sheet, if necessary): 
 
Subject falls into one of these three categories: 
 Having characteristically normal respiratory health 
 Having pneumonia 
 Having asthma 
 
Exclusion criteria (include additional sheet if necessary): 
 
 Not willing to participate 
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SECTION VI (continued) 
 
 
Describe, in detail, the plan of investigation, procedures and methods.  Include procedures 
and forms to be collected at each visit, who will be conducting visits, interviews and/or 
reviewing medical records. 
 
Subjects will be regular patients of May Street Pediatrics who agree to become part of 
the study by completing the consent form. Patients may be asked to join the study if, 
in the opinion of Dr. Eder, the sound produced by their lungs during breathing is 
characteristic of one of three populations: being of normal respiratory health, having 
pneumonia or an upper or lower respiratory infection, or being asthmatic. The study 
will consist of a single one to two minute lung-sound recording session for each 
subject, which can be conducted immediately following the subject’s enrollment, or 
on a subsequent visit to Dr. Eder’s office. In some cases, at the discretion of Dr. Eder, 
and with additional consent from the subject, one or two additional sessions may be 
conducted. (This will only occur if Dr. Eder believes that there may have been a 
change in the subject’s health, and he or she has become a member of a different 
population.) 
 
During the recording session, Dr. Eder will place a microphone, identical in size and 
shape to the diaphragm of a small stethoscope, on the subject’s back, in six to eight 
positions. At each position, the subject will be asked to breathe at a steady pace 
slightly deeper than normal, while an audio recording is made of the sound 
propagating from the lungs. The procedure will be as similar as possible to standard 
stethoscopic respiratory auscultation. 
 
Each recording will be labeled with only a number, with which will be associated only 
an age, sex, and respiratory diagnosis category (i.e. healthy, having pneumonia or a 
respiratory infection, or asthmatic). No personally identifiable information will leave 
the Fallon facility, and thus only Dr. Eder will be aware of the identity of each subject. 
 
 
 
Will questionnaires be administered? Yes____  No__X__ (if yes, submit 5 
copies of each) 
Will billing information or data be abstracted from medical records? Yes_____  No_ X__ 
(if yes, submit 5 copies of data collection sheet) 
Will video or audiotapes be used?  Yes_____ No__ X__ (if yes, submit 1 
copy) 
Will there be advertising?   Yes_____ No__ X__ 
 
Please note that all advertising requires prior approval by the IRB.  Fallon clinic advertising 
also needs approval by the communications department.  Please list where advertising will be 
located (i.e., FC newsletter, postings at sites, Worcester telegram, radio…)    
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SECTION VII 
Risks and Benefits: 
 
Outline potential risks to subjects and methods of management if damage occurs: 
 
No potential risks are identified for this study. The microphone will be sanitized before and after 
each use. 
 
Outline potential benefit to subject and/or society in general: 
 
Although there are no direct benefits to the subject, this research project will contribute to 
general scientific knowledge, and may ultimately lead to a better process of diagnosing 
respiratory disease. 
 
Will the patient receive information about the results of the experimental procedures? 
 
No. 
 
Will the patient's primary physician receive information about the results of the experimental 
procedures? 
        
Yes, within the May Street Clinic. 
 
Under what circumstances will a patient be removed from the study? 
 
At any time at which they no longer volunteer to be a participant. 
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SECTION VIII 
 
Drugs: 
 
If drugs are to be administered to subjects is the drug(s) approved by the FDA for this use?   
N/A 
 
If not, please indicate phase of study and supply the IND number:  N/A 
 
 
If medications are used in this trial, please explain the type of medication, its mechanism of 
action (if known) and how this action compares to those of the other drugs being studied as 
well as standard treatment. 
 
DRUG NAMES  DOSES  DRUG SIDE EFFECTS   % 
INCIDENCE 
 N/A N/A N/A N/A 
 
Where will drugs be stored? (Please note that mass DPH regulations stipulate all drugs must 
be kept in a locked cabinet.  Controlled substances should be dispensed through the pharmacy 
and kept in double locked cabinet. )   N/A 
 
 
Who will administer drugs?  N/A 
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SECTION IX 
 
Medical Devices: 
 
a)  Name Of Device: TSD108 (Physiological Sounds Microphone), produced by BIOPAC Systems, 
Inc. 
b)  FDA Approved?          Yes    X    No   
C)  If Not Approved:  IDE#                    
D)           Significant Risk Device    X   Non-Signif. Risk Device 
 (Please Include Supporting Materials From Sponsor & Any  
      Correspondence With FDA) 
 
The Physiological Sounds Microphone was developed to use with the BIOPAC acquisition system. 
This system – consisting of a microphone connected to a analog-digital converter – is designed for 
use on humans for research and educational applications. The system is used extensively at many 
educational institutions, including WPI, to allow students to make non-invasive recordings of their 
own body sounds and bioelectric signals. 
 
This system does not pose any significant risk to the subjects in this study. 
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SECTION X 
(must be completed) 
 
Funding & Support: 
 
Source of funding:  please include name of sponsor, and explain how this project will be 
supported.    
 
Worcester Polytechnic Institute is the sponsor for this study; no special funding is required. 
 
What clinic/hospital resources will be required to conduct the study? 
 
A single lockable room housing the computer recording system will be allocated for the study. 
 
Personnel (include nursing, clerical, medical record, pharmacy,  
MIS requirements & patient accounts/billing):   the PI and some nursing staff 
 
Equipment:  none 
 
Supplies:  alcohol swaps 
 
Who will be financially responsible for the following procedures/ office visits required for the 
study? Please be specific as to type and number of visit/tests(s). Please also indicate whether or 
not you consider these standard care. 
 
for office visits? Study will be conducted during regular patient office visits; therefore, no 
extended financial responsibilities exist. 
 
for medications? N/A 
 
for labs?  (include number of blood & urine specimens and amount of blood to be drawn) 
(please indicate whether labs will be processed by PathLab or sent to a central 
lab).   N/A 
 
for x-rays? N/A 
 
for ekgs and other tests? (identify other tests) N/A 
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SECTION X (continued) 
(must be completed) 
 
Will health care professionals receive finder's fees for referring patients to the study?  No. 
 
Will the patient be financially reimbursed for participation? If yes, elaborate.  No. 
 
 
  
 
 
FORM REVISED 11/3/03 
mc 
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FALLON CLINIC 
RESEARCH CONFLICT OF INTEREST POLICY 
 
SUMMARY:  It is the policy of the Fallon Clinic, Inc. that its staff act in accordance with the 
highest ethical and professional standards in the conduct of research.  This policy provides a 
definition of conflict of interest, investigator/staff disclosure and reporting requirements and how 
these conflicts will be reviewed and resolved. Any question of a conflict of interest must be 
resolved by the Research Department (and the IRB and Fallon Clinic Medical Director, if 
necessary), not the individual researcher or other staff. 
 
DEFINITION:  A conflict of interest exists when financial considerations or publication rights 
compromise or have the appearance of compromising one’s professional judgment and 
independence in the design, conduct or publication of research. 
 
The following situations are examples of potential conflicts of interest and are reportable to the 
Research Department:   
 
• Any equity interest in the sponsoring company exceeding $ 10,000 or 5% ownership during 
the conduct of the research or within one year after termination of the research study 
• Serving as a paid consultant or speaker on behalf of the sponsor 
• Any proprietary interests in the products including patents, trademarks, copyrights and 
licensing agreements 
• Any initial payments to the investigator or institution that goes beyond what is required to 
carry out the research study 
• Any financial gain for the investigator/staff, IRB member or the institution if the study shows 
an outcome favorable to the research sponsor 
• Any agreement with a sponsor that restricts publication or delays access to research 
information other than short-term delay to allow sponsor the opportunity to review any 
potential publications 
• Any payment for services or royalties paid directly to investigators or consultants that could 
exceed $10,000 per year on a particular research project 
• Any recruitment bonuses paid directly to the investigator or staff  
 
POLICY APPLIES TO THE FOLLOWING INDIVIDUALS: 
• All Fallon investigators conducting research at the Clinic  
• Investigator’s spouse, dependent or any associated entity 
• All study coordinators participating in a research project 
• Fallon consultants 
• Other clinic or hospital staff 
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FALLON CLINIC SUBMISSION AND REVIEW OF 
DISCLOSURE FORMS 
 
• Research staff: Will be required to complete and submit “Research Conflict of Interest 
Certification” Form, along with the Research Finance Report, to the Fallon Clinic Medical 
Director of Research, prior to approval of each study.  Staff will also be asked to update this 
form annually (at the time of continuing review) for each ongoing study.  The IRB 
Administrator will submit the forms to the Fallon Clinic Medical Director of Research.  He 
will forward information about any potential conflicts of interest, along with his 
recommendation, to the Institutional Review Board.  If a conflict of interest that may 
compromise the conduct of the study is identified, the information will be forwarded to the 
Fallon Clinic Medical Director who will determine whether further action will be needed  
• Other clinic or hospital staff: Proposals for recruitment bonuses to physicians, nurses or 
other clinic or hospital staff must be submitted to the IRB for approval.  The amount of the 
stipend must be in direct relationship to the time required to identify and refer appropriate 
patients. 
 
DISCLOSURE TO RESEARCH SUBJECTS: 
All Patient Consent Form(s) will include the following disclosure information: 
• Name of sponsor 
• A clause that discloses that the organization and/or staff may be compensated for 
participation in the study.  A recommended clause is, “Fallon Clinic (include Saint Vincent 
Hospital if applicable) and/or the doctors involved in this trial may receive funding from the 
study sponsor for conduct of this research study.  If you have any questions about this, please 
discuss them with the Institutional Review Board at (508) 852-0600, extension 33058.”  
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FALLON CLINIC 
RESEARCH CONFLICT OF INTEREST 
CERTIFICATION FORM 
 
NAME:    Thomas J. Eder, M.D. 
 
DEPARTMENT:  Pediatrics 
 
PROJECT # AND TITLE OF PROJECT: Automated Stethoscope System 
 
NAME OF SPONSORING COMPANY:  Worcester Polytechnic Institute 
 
 
? I HAVE NO POTENTIAL CONFLICTS OF INTEREST AS DEFINED IN THE 
FALLON CLINIC RESEARCH CONFLICT OF INTEREST POLICY. 
 
? I HAVE POTENTIAL CONFLICTS OF INTEREST AS FOLLOWS  (details should be 
included below): 
 
? Equity interest in the sponsoring company (that exceeds $ 10,000 or 5% ownership) 
during the conduct of the research or within one year after termination of the research 
study (including that to my spouse or children) 
 
? Serve as a paid consultant or speaker on behalf of the sponsor (including spouse or 
children) 
 
? Payment for services or royalties paid directly to investigators or consultants that could 
exceed $10,000 per year on a particular research project. 
 
? Other 
 
 
If potential conflict of interest is indicated above, please explain why it will not impact conduct 
of the study. 
 
 
 
_______________________________________________                 ____________ 
Signature                                                                                            Date 
 
Fallon Clinic Financial conflict of interest.doc 
12/10/2002. 
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APPENDIX B – ELECTRONIC STETHOSCOPES 
Contents: 
Andromed: Androscope Stethos 
 
Meditron: The Meditron Stethoscope  
 
Cardionics: E-Scope II 
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Andromed: Androscope Stethos 
 
 
Specifications: 
Supply Voltage: 3.0VDC 
Supply Current: 3.5mA (typical) 
Temperature: 0ºC to 50ºC (operation); -20ºC to 60ºC (storage) 
Humidity: 15 to 95%RH 
Altitude: Up to 4550m 
Length: Model ST28A00: 28" (71cm) length 
Model ST40A00: 40" (102 cm) length 
Weight: ~ 145g-165g 
http://www.andromed.com 
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Meditron: The Meditron Stethoscope 
 
Specifications: 
• Exceptional Sound Quality  
• Extended frequency settings from  
20 - 20 000 Hz  
• Connectable to PC for PCGs with ECG  
• Easy-to-use  
  
The Essentials of Auscultation 
The Meditron Stethoscopes is based on 
innovative, patented sensor technology, and 
outperforms all other stethoscopes both in prize 
awarded design and sound quality.  
Its sensor technology gives you the freedom to perform auscultation under the most 
demanding situations or in your office as usual. Listen through clothes, bandages, thick 
fatty tissue or fur, and still hear more and more accurately than before.  
Foremost, the Meditron Stethoscopes has revolutionized the way doctors and vets can 
perform auscultation in their practices. Hearing, visualizing and documenting auscultation 
findings are now possible, with the touch of a button. 
  
Early Diagnosis - Better Prognosis 
Use the Meditron Stethoscopes, and improve your auscultation skills. Hear sounds that are 
present at early stages in infectious and functional diseases. This will increase your chances 
of making earlier and more correct diagnoses, and thereby improve your patient's 
prognosis.  
Document your findings, analyze them and view them as PCG's with ECG on your PC. This 
will reduce uncertainty, save time and secure your work.  
A second opinion is also only a touch away, due to a special e-mail function in the Meditron 
Analyzer ECG software. 
  
Unique Features 
• Exceptional Sound Quality  
• 3 predefined frequency settings - tune into the sounds you wish to focus on.  
o Heart 20-600 Hz  
o Lung 200 20 000 Hz  
o Extended frequency setting 20-20 000 Hz 
• Amplification of sound up to 30 times greater than conventional stethoscopes  
• Connectable to PC for hearing, visualizing and documenting auscultation findings  
• On/off button with timer function (3 min.)  
• Adjustable ear plugs  
• 2 Batteries - lifetime 200 hours 2-4 years normal usage)  
• Price awarded design.  
  
  
http://www.meditron.no/ 
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Cardionics: E-Scope II 
 
Specifications:  
   
Maximum Output: 124 dB SPL, 
undistorted  
 
The maximum volume of the E-Scope 
II is approximately 30x louder than an 
 acoustic stethoscope  
   
Audio Gain: 27 dB @ 200 Hz 
(SPL/SPL) Peak output for both heart 
and  
breath sounds.  
   
Heart Sounds: 100-240 Hz (-3dB) SPL 
SPL  
45-900 Hz (-20 dB)  
   
Breath Sounds: 125 to 350 Hz (-3dB)  
50-2000 Hz (-20dB)  
   
Weight: 6.2 oz  
   
Cord Length: 38 inches from chest piece to binaural earpieces  
   
Restart: 2 minute timer  
   
Battery: One AAA battery can power the E-Scope II for approximately 6  months at 6 hours 
usage per week, or 30 uses per day.  
   
Warranty: One year Warranty.  Lifetime technical support.  
 
http://www.cardionics.com 
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APPENDIX C – ALGORITHM IMPLEMENTATIONS 
Source code for crackle detection: 
function crackle_ratio = cracklefind(y,Fs) 
NFFT = 2048; 
WINDOW = 128; 
MINFRACTION = 0.6; 
MAXFRACTION = 1.0; 
MINFREQ = 200; 
MAXFREQ = 1500; 
MINTIME = 0; 
MAXTIME = 9.5; 
% Defining width of the crackle 
widthMIN=1; 
widthMAX=3; 
  
DISPLAY_IMAGES = 0; 
  
[B,Freqs,Times] = specgram(y,NFFT,Fs,WINDOW); 
MINFREQ = sum(Freqs <= MINFREQ); 
MAXFREQ = sum(Freqs <= MAXFREQ); 
MINTIME = sum(Times <= MINTIME); 
MAXTIME = sum(Times <= MAXTIME); 
  
%image is B(freq,time) 
specdata = (20*log10(abs(B)))'; 
if DISPLAY_IMAGES 
    figure 
    imagesc(Times(MINTIME:MAXTIME),Freqs,specdata(MINTIME:MAXTIME,:)'),axis xy, colormap('jet') 
end 
  
howbig = size(specdata); 
  
baseline = -20; 
BWdata = (specdata > baseline); 
  
if DISPLAY_IMAGES > 2 
    figure 
    imagesc(Times(MINTIME:MAXTIME),Freqs(MINFREQ:MAXFREQ),... 
        BWdata(MINTIME:MAXTIME,MINFREQ:MAXFREQ)'),axis xy, colormap('jet') 
end 
line = (mean(BWdata(MINTIME:MAXTIME,MINFREQ:MAXFREQ),2) > MINFRACTION)' .* ... 
    (mean(BWdata(MINTIME:MAXTIME,MINFREQ:MAXFREQ),2) < MAXFRACTION)'; 
  
newline = zeros(size(line)); 
  
ones=0; % ones counter 
  
for i=1:size(line,2) 
    % increment the counter of pre-crackles 
    if line(i) 
        ones = ones + 1; 
    end 
  
    % a crackle is defined as a set width of 1s followed by a 0 
    if (line(i) == 0) 
        if (ones >= widthMIN) & (ones <= widthMAX) 
            newline(i) = 1; 
        end 
        ones=0; 
    end 
end 
  
if DISPLAY_IMAGES > 2 
    figure 
    imagesc(Times(MINTIME:MAXTIME),Freqs,line),axis xy,colormap(jet) 
end 
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if DISPLAY_IMAGES 
    figure 
    imagesc(Times(MINTIME:MAXTIME),Freqs,newline),axis xy,colormap('cool') 
end 
crackle_ratio = mean(newline); 
end 
 
 119
Source code for wheeze detection: 
function wheeze_ratio = wheezefind(y,Fs) 
%Spectrogram parameters: 
NFFT = 2048; 
WINDOW = 128; 
numoverlap = 108; 
  
DISPLAY_IMAGES = 0; 
  
%window of interest (Hz, Seconds) 
MINFREQ = 200; 
MAXFREQ = 2200; 
MINTIME = 0; 
MAXTIME = 10; 
  
%define length of wheezes 
widthMIN=25; 
widthMAX=10000; 
  
 [B,Freqs,Times] = specgram(y,NFFT,Fs,WINDOW,numoverlap); 
MINFREQ = sum(Freqs <= MINFREQ); 
MAXFREQ = sum(Freqs <= MAXFREQ); 
MINTIME = sum(Times <= MINTIME); 
MAXTIME = sum(Times <= MAXTIME); 
  
B = abs(B); 
  
if DISPLAY_IMAGES 
    figure 
    imagesc(Times(MINTIME:MAXTIME),Freqs,20*log10(B(:,MINTIME:MAXTIME))),axis xy, colormap('jet') 
end 
  
%image is B(freq,time) 
specdata = B'; 
peaksmap = specdata; 
 
% %%%%%%%%%VECTOR METHOD%%%%%%%%%%% 
the_mean = repmat(mean(specdata(MINTIME:MAXTIME,:),2),1,length(Freqs)); 
column = specdata(MINTIME:MAXTIME,:) - the_mean; 
variance = repmat(sqrt(1./(length(Freqs)*sum((column.^2),2))),1,length(Freqs)); 
column = column ./ variance; 
peaks = (column > (.5*variance)) .* ((column - circshift(column,[0 1])) > 0) .* ((column - ... 
    circshift(column,[0 -1])) > 0); 
peakdisp = peaks | circshift(peaks,[0 1]) | circshift(peaks,[1 1]) | circshift(peaks,[1 0]); 
  
if DISPLAY_IMAGES 
    figure 
    imagesc(Times(MINTIME:MAXTIME),Freqs(MINFREQ:MAXFREQ),... 
        (peakdisp(MINTIME:MAXTIME,MINFREQ:MAXFREQ)')),axis xy, colormap('jet') 
end 
  
peakscore = peaks .* ((column - (circshift(column,[0 1]) + circshift(column,[0 2]) + ... 
    circshift(column,[0 3])) / 3) > (2.5*variance)); 
peakscore = peakscore + peaks .* ((column - ((circshift(column,[0 -1]) + ... 
    circshift(column,[0 -2]) + circshift(column,[0 -3])) / 3)) > (2.5*variance)); 
peakscore = peakscore + peaks .* (((column - circshift(column,[0 1])) > (2*variance)) .* ... 
    ((column - circshift(column,[0 -1])) > (2*variance))); 
peakscore = peakscore + peaks .* (((column - circshift(column,[0 2])) > (3.5*variance)) .* ... 
    ((column - circshift(column,[0 -2])) > (3.5*variance))); 
peakscore = peakscore - peaks .* (1 - (column - ((... 
    circshift(peaks,[0 1]) + circshift(peaks,[0 2]) + circshift(peaks,[0 3]) + ... 
    circshift(peaks,[0 -1]) + circshift(peaks,[0 -2]) + circshift(peaks,[0 -3])) / 6) > 0)); 
peakscore = peakscore + peaks .* ((column - ((... 
    circshift(column,[0 1]) + circshift(column,[0 2]) + circshift(column,[0 3]) + ... 
    circshift(column,[0 -1]) + circshift(column,[0 -2]) + circshift(column,[0 -3])) / 6)) ... 
    > (3*variance)); 
peaksmap = peakscore; 
%%%%%%%%%%%%%%%%% 
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if DISPLAY_IMAGES 
    figure 
    imagesc(Times(MINTIME:MAXTIME),Freqs(MINFREQ:MAXFREQ), ... 
        (peaksmap(MINTIME:MAXTIME,MINFREQ:MAXFREQ)')),axis xy, colormap('jet') 
end 
  
line = sum(peaksmap(MINTIME:MAXTIME,MINFREQ:MAXFREQ),2); 
if DISPLAY_IMAGES 
    figure 
    imagesc(Times(MINTIME:MAXTIME),Freqs(MINFREQ:MAXFREQ),line'),axis xy, colormap('jet') 
end 
  
newline = zeros(size(line)); 
ones=0; % ones counter 
prom=0; 
  
for i=1:length(line) 
    % increment the counter of pre-wheezes 
    if line(i) 
        prom = prom + line(i); 
        ones = ones + 1; 
    end 
  
    % a wheeze is defined as a set (width*prominence) product of 1s followed by a 0 
    if (line(i) == 0) 
        if (prom >= widthMIN) & (prom <= widthMAX) 
            %mark with a band 
            for n = 0:ones 
                if i-n > 0 
                    newline(i-n) = 1; 
                end 
            end 
        end 
        ones=0; 
        prom=0; 
    end 
end 
  
if DISPLAY_IMAGES 
    figure 
    imagesc(Times(MINTIME:MAXTIME),Freqs,newline'),axis xy,colormap('jet') 
end 
  
wheeze_ratio = mean(newline); 
end 
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APPENDIX D – DATA FROM CLINICAL TRIAL 
 
Adventitious Sounds Detection Data (First Stage of Software Algorithm) 
 
     
MEAN & 
STDEV 
MEAN & 
STDEV 
Subject Recording Crackles Wheezes  Crackles Wheezes 
0 0 0.00735294 0  0.00173833 0.002498902 
0 1 0 0.01257445  0.00285199 0.005029932 
0 2 0.00154799 0.00241896    
0 3 0 0    
0 4 0 0    
0 5 0.00152905 0    
       
1 0 0.0052356 0  0.001736495 0.008669322 
1 1 0.00204918 0.01474359  0.001920033 0.010111027 
1 2 0 0.02364217    
1 3 0.00160514 0    
1 4 0 0    
1 5 0.00152905 0.01363017    
       
2 0 0 0.00535236  0.010064643 0.003549922 
2 1 0.00498753 0.00311769  0.018852607 0.002139285 
2 2 0.00462963 0.00289855    
2 3 0.00247525 0.00386698    
2 4 0.04829545 0    
2 5 0 0.00606395    
       
3 0 0.00660793 0.02687802  0.002170237 0.020045132 
3 1 0 0  0.002682609 0.018859679 
3 2 0 0.01181281    
3 3 0.00327869 0.026653    
3 4 0 0.05100539    
3 5 0.0031348 0.00392157    
       
4 0 0.00665188 0.02081888  0.008956057 0.028944413 
4 1 0.01794872 0.02487961  0.008090522 0.01075061 
4 2 0.00226757 0.04113475    
       
5 0 0.01879699 0.03055229  0.005897943 0.01254912 
5 1 0.00506329 0  0.007786268 0.014234494 
5 2 0 0    
5 3 0 0    
5 4 0 0.02580645    
5 5 0.01152738 0.01893598    
       
6 0 0.00821918 0  0.002740132 0.01095028 
6 1 0 0.00690955  0.003421076 0.021952651 
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6 2 0.00516351 0.05540613    
6 3 0 0    
6 4 0 0.003386    
6 5 0.0030581 0    
       
7 0 0.00972763 0.00486618  0.003277062 0.004838422 
7 1 0 0  0.003754429 0.004112254 
7 2 0.00534759 0.00780814    
7 3 0 0.00636075    
7 4 0.00152905 0.00999546    
7 5 0.0030581 0    
       
8 0 0.05645161 0.05555556  0.038880633 0.237834697 
8 1 0.0596206 0.20695505  0.020386559 0.12699259 
8 2 0.05399568 0.22079676    
8 3 0.01939058 0.40034662    
8 4 0.03071672 0.17822839    
8 5 0.01310861 0.3651258    
       
9 0 0 0  0 0.015768285 
9 1 0 0  0 0.018650654 
9 2 0 0.02173913    
9 3 0 0.0029703    
9 4 0 0.04733219    
9 5 0 0.02256809    
       
10 0 0.01552106 0.00346981  0.00822094 0.004017903 
10 1 0.01223242 0.0052531  0.007229477 0.002556552 
10 2 0 0    
10 3 0.00611621 0.00318037    
10 4 0.01545595 0.0077332    
10 5 0 0.00447094    
       
11 0 0.01581028 0.00618047  0.015986892 0.015507725 
11 1 0.0166113 0.00728408  0.002050173 0.015725622 
11 2 0.01935484 0    
11 3 0.01587302 0.0417495    
11 4 0.01522843 0.02696273    
11 5 0.01304348 0.01086957    
       
12 0 0 0.00772376  0.000254842 0.00219597 
12 1 0 0.00272603  0.000624232 0.003019445 
12 2 0 0    
12 3 0 0.00272603    
12 4 0.00152905 0    
12 5 0 0    
       
13 0 0 0  0.000526615 0.000245458 
13 1 0 0  0.000815853 0.000601248 
13 2 0.00158983 0    
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13 3 0 0    
13 4 0.00156986 0.00147275    
13 5 0 0    
       
14 0 0.03030303 0.02525253  0.02536623 0.019169305 
14 1 0.04395604 0.02257115  0.014767527 0.009801144 
14 2 0.01166181 0.00456204    
14 3 0.01554404 0.0242915    
       
15 0 0 0.00136302  0.001315402 0.00331651 
15 1 0 0.00582319  0.002456877 0.003055749 
15 2 0 0.00811771    
15 3 0.0017762 0.00277778    
15 4 0 0    
15 5 0.00611621 0.00181736    
       
16 0 0.00152905 0.00272603  0.002850387 0.01044568 
16 1 0.00395257 0.0148423  0.001063097 0.006390739 
16 2 0.00343643 0.01988178    
16 3 0.00152905 0.01226715    
16 4 0.0030581 0.00732936    
16 5 0.00359712 0.00562746    
       
17 0 0.01587302 0.00247934  0.005450995 0.003231405 
17 1 0.0021645 0  0.00573389 0.004995137 
17 2 0.0025641 0.01283079    
17 3 0 0    
17 4 0.0078125 0.0040783    
17 5 0.00429185 0    
       
18 0 0.05463183 0.1218425  0.011642722 0.022129497 
18 1 0.0019802 0  0.021291181 0.048948038 
18 2 0 0    
18 3 0.00225225 0    
18 4 0.00190114 0.00297089    
18 5 0.00909091 0.00796359    
       
19 0 0.05660377 0.14201183  0.031048133 0.342677602 
19 1 0.04281346 0.49386642  0.01895449 0.136382453 
19 2 0.03318584 0.31163435    
19 3 0.02752294 0.40208996    
19 4 0 0.24107143    
19 5 0.02616279 0.46539162    
       
20 0 0.00179211 0.03533371  0.00190136 0.010759027 
20 1 0 0  0.002815883 0.013198852 
20 2 0 0.01118568    
20 3 0.00724638 0.01284958    
20 4 0 0    
20 5 0.00236967 0.00518519    
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21 0 0.01428571 0.03910615  0.015519825 0.031522077 
21 1 0 0  0.013590629 0.038956196 
21 2 0.03183521 0.02925688    
21 3 0.00959693 0.01140456    
21 4 0.00529101 0.00441258    
21 5 0.03211009 0.10495229    
       
22 0 0 0  0.000916762 0.002957652 
22 1 0.00243309 0.01294745  0.001434339 0.005256909 
22 2 0 0    
22 3 0.00306748 0.00479846    
22 4 0 0    
22 5 0 0    
       
23 0 0.00546448 0.00341491  0.003764653 0.001231842 
23 1 0 0  0.004293751 0.001916596 
23 2 0 0    
23 3 0.00794913 0.00397614    
23 4 0 0    
23 5 0.00917431 0    
       
24 0 0 0  0.001033792 0 
24 1 0 0  0.001601777 0 
24 2 0 0    
24 3 0.00314465 0    
24 4 0.0030581 0    
24 5 0 0    
       
25 0 0.00584795 0.0195003  0.005034857 0.013291095 
25 1 0.00911162 0.0113879  0.003339467 0.006164969 
25 2 0.00507614 0.02065131    
25 3 0 0.01349206    
25 4 0.00252525 0.00394945    
25 5 0.00764818 0.01076555    
       
27 0 0.07 0  0.034709783 0.030362685 
27 1 0.02540835 0.02101079  0.024558753 0.040584469 
27 2 0.03007519 0.01057579    
27 3 0.01335559 0.08986416    
       
28 0 0.01223242 0.0081781  0.00590787 0.008677807 
28 1 0.00611621 0.0081781  0.004354818 0.00986802 
28 2 0 0    
28 3 0.00486618 0.00380518    
28 4 0.00917431 0.02781641    
28 5 0.0030581 0.00408905    
       
29 0 0.01580135 0.00353357  0.00350881 0.011582373 
29 1 0.00310559 0.00678952  0.006165417 0.010933012 
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29 2 0 0.02885482    
29 3 0 0    
29 4 0 0.02024922    
29 5 0.00214592 0.01006711    
       
30 0 0.02380952 0.00802292  0.006334643 0.01953557 
30 1 0 0.00219419  0.011672196 0.023900631 
30 2 0 0.05474934    
30 3 0.00152905 0.01317583    
       
31 0 0.00225225 0.00634697  0.008735558 0.004252672 
31 1 0 0.00796524  0.00987123 0.003775025 
31 2 0 0.00302572    
31 3 0.01767677 0    
31 4 0.02331002 0    
31 5 0.00917431 0.0081781    
       
32 0 0.00458716 0.00181736  0.002039777 0.00501976 
32 1 0 0.00499773  0.002679563 0.003781474 
32 2 0.00612245 0.00574713    
32 3 0 0.00272603    
32 4 0 0.01210428    
32 5 0.00152905 0.00272603    
       
33 0 0.00323625 0  0.013568502 0.02276094 
33 1 0 0  0.019705635 0.054647348 
33 2 0.01603206 0    
33 3 0.05166052 0.13429395    
33 4 0.01048218 0    
33 5 0 0.00227169    
       
34 0 0 0  0.001858498 0.002889407 
34 1 0.00176367 0  0.001983854 0.00447371 
34 2 0.00190476 0.00357569    
34 3 0.00542495 0.00225989    
34 4 0 0.01150086    
34 5 0.00205761 0    
       
35 0 0 0.01544752  0.004942132 0.029474678 
35 1 0.00456621 0  0.005675549 0.035598978 
35 2 0.00638298 0.0505992    
35 3 0.01376147 0.08132667    
35 4 0 0    
       
36 0 0 0.00447177  0.00204259 0.007740647 
36 1 0.00244499 0.00612089  0.002833846 0.010174691 
36 2 0.00255102 0    
36 3 0 0    
36 4 0 0.02733333    
36 5 0.00725953 0.00851789    
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37 0 0.02022472 0.10892481  0.011214105 0.054972523 
37 1 0.01223242 0.1138756  0.00715425 0.044505394 
37 2 0.01892744 0.02371542    
37 3 0.004914 0.04221028    
37 4 0.003367 0.01789474    
37 5 0.00761905 0.02321429    
       
38 0 0.00810373 0  0.003644198 0.00242314 
38 1 0.00458716 0  0.002649049 0.004401852 
38 2 0.0030581 0.00363471    
38 3 0.0030581 0    
38 4 0 0    
38 5 0.0030581 0.01090413    
       
39 0 0 0  0.002293578 0.003521125 
39 1 0.00611621 0.00363471  0.002927912 0.003447691 
39 2 0 0.00227169    
39 3 0.0030581 0.0081781    
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Scoring Data (Second Stage of Software Algorithm) 
 
Subject 
Asthma 
Score 
Pneumonia 
Score  
Normalized 
Asthma 
Score 
Normalized 
Pneumonia 
Score 
5 4.5923E-05 0.881599282  0.538730685 3.508681971
6 9.3742E-06 0.498813571  0.109970433 1.985230954
7 1.23035E-05 1.176586224  0.144334539 4.682702173
8 0.000792642 1.87282342  9.298631758 7.453660529
9 0 0.845454801  0 3.364830347
10 5.94331E-05 1.571610077  0.697220508 6.25485984
11 3.27759E-05 0.986143824  0.384500081 3.924759386
12 1.5908E-07 0.727276026  0.0018662 2.894489971
13 4.2964E-07 0.40824829  0.00504019 1.624789682
14 0.000374596 1.955823296  4.394459801 7.783992205
15 3.23178E-06 1.085334575  0.037912602 4.319529218
16 3.03024E-06 1.6345028  0.035548255 6.505166943
17 3.12554E-05 0.646910206  0.366662885 2.57464159
18 0.000247887 0.452101814  2.908011033 1.799322567
19 0.000588502 2.512622372  6.903818827 10
20 5.35401E-06 0.81514867  0.062808847 3.244214806
21 0.000210924 0.809167212  2.474390162 3.220409165
22 1.31495E-06 0.562621815  0.015425889 2.239181746
23 1.61645E-05 0.642723782  0.189628509 2.557980019
24 1.6559E-06 0  0.019425709 0
25 1.68137E-05 2.155906078  0.19724501 8.5803028
27 0.000852429 0.748135578  10 2.977509019
28 2.57277E-05 0.879386846  0.301816336 3.499876685
29 2.16333E-05 1.059394585  0.253783922 4.216290504
30 7.39392E-05 0.817366292  0.867394095 3.253040733
31 8.62307E-05 1.126527994  1.011588186 4.483475137
32 5.46571E-06 1.327461118  0.064119245 5.283170018
33 0.000267376 0.416505847  3.136635978 1.657653979
34 3.68699E-06 0.645863613  0.04325275 2.570476247
35 2.80493E-05 0.827964161  0.329051596 3.295219251
36 5.78839E-06 0.760774582  0.067904603 3.027811063
37 8.02285E-05 1.235187884  0.94117534 4.915931249
38 9.65366E-06 0.550481883  0.113248866 2.19086596
39 6.71539E-06 1.021299371  0.078779507 4.064675147
 
 
